{"study_id": 29236, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the relationship between dietary intake, particularly omega-6 fatty acids, and brown adipose tissue (BAT) activity in healthy males.", "results_summary": "The study found that lower omega-6 fatty acid intake was significantly associated with detected BAT activity, suggesting a potential link between dietary omega-6 and BAT function. BAT presence was also linked to lower visceral adipose tissue and higher serum IL-6 levels during cold exposure.", "population_specificity": "28 healthy non-smoking males aged 21-42 years, including normal-weight and overweight/obese individuals.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:56.743962+00:00"}
{"study_id": 29237, "supplement_id": 1397, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Omega-6 fatty acids, specifically arachidonic acid (AA), could enhance the effectiveness of doxorubicin (dox) chemotherapy in Her2-amplified breast cancer cells by increasing lipid peroxidation and 4-HNE generation while sparing cardiomyocytes.", "results_summary": "AA increased lipid peroxidation, 4-HNE generation, apoptosis, cellular dox concentration, and dox cytotoxicity in Her2-amplified breast cancer cell lines (SK-BR-3 and AU565) without harming cultured cardiomyocytes. AA also inhibited Rlip functions, suggesting a synergistic effect with dox or Rlip inhibitors.", "population_specificity": "Her2-amplified breast cancer cell lines (SK-BR-3 and AU565) and immortalized cardiomyocyte cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:58.893269+00:00"}
{"study_id": 29239, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of omega-6 fatty acid arachidonic acid (AA) with omega-3 fatty acids (EPA and DHA) on nitric oxide bioavailability and fatty acid composition in endothelial cells.", "results_summary": "AA did not affect nitric oxide (NO) or peroxynitrite (ONOO-) release, unlike EPA and DHA, which increased NO levels. AA treatment decreased the EPA/AA ratio 4-fold, indicating a negative impact on omega-3 fatty acid content.", "population_specificity": "Human umbilical vein endothelial cells (HUVECs)", "effective_dosage": "10 \u00b5M", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:03.579123+00:00"}
{"study_id": 29238, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine if Neuroaspis PLP10\u2122, containing omega-6 fatty acids, could improve Parkinson's disease symptoms and delay disease progression when used as an adjuvant to conventional treatment.", "results_summary": "Neuroaspis PLP10\u2122 supplementation significantly delayed Parkinson's disease progression according to UPDRS scores (p \u2264 0.05) compared to placebo over 30 months. The study suggests potential benefits of omega-6 fatty acids in managing Parkinson's disease symptoms.", "population_specificity": "40 patients with Parkinson's disease.", "effective_dosage": "1800 mg gamma-Linolenic acid and 3150 mg Linoleic acid (1:1 w/w), administered once daily in a 20 ml dose.", "study_duration": "30 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:04.301271+00:00"}
{"study_id": 29242, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 82, "study_goal": "The researchers aimed to analyze red blood cell membrane fatty acid profiles in breast cancer patients to identify potential biomarkers and therapeutic targets related to Omega-6 Fatty Acids.", "results_summary": "The study found that breast cancer patients had higher levels of Omega-6 Fatty Acids (C18:2 and C20:4) compared to controls, suggesting that Omega-6 pathways are favored in these patients. These findings indicate potential targets for treatments and nutritional guidelines.", "population_specificity": "Recently diagnosed breast cancer patients before starting chemotherapy treatment.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:04.422746+00:00"}
{"study_id": 29243, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of an Omega-3/Omega-6 fatty acid supplement in reducing ADHD symptoms and related behavioral problems in preschool children at risk for ADHD.", "results_summary": "The study found moderate positive effects on parent- and teacher-rated ADHD symptoms, internalizing symptoms, and externalizing symptoms, though results require replication in larger samples for stronger conclusions.", "population_specificity": "Preschool children with elevated ADHD symptoms (n=40).", "effective_dosage": "Not specified", "study_duration": "4 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:04.707857+00:00"}
{"study_id": 29241, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of different omega-3 and omega-6 fatty acid sources on ovarian response and embryo quality in Boer does undergoing superovulation treatment.", "results_summary": "Linseed oil (LO) supplementation resulted in a higher number of ova/embryos recovered and transferable embryos compared to soybean oil (SO), palm oil (PO), and control (CO), while also preventing premature luteal regression. Other treatments showed no significant differences in ovulation numbers or estrous response.", "population_specificity": "Pluriparous Boer does (goats)", "effective_dosage": "300 g of experimental supplements (LO, SO, PO, or CO) daily", "study_duration": "15 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:05.609556+00:00"}
{"study_id": 29240, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of saturated fatty acids (SFAs) and omega-6 PUFAs on the incorporation of omega-3 PUFAs into milk and tissues of lactating mice and their offspring.", "results_summary": "High-linoleic-acid (HLA) diets decreased omega-3 PUFA concentrations in multiple pup tissues compared to high-SFA diets, suggesting that omega-6 PUFAs suppress omega-3 PUFA incorporation in neonates. Both SAT and HLA diets reduced milk omega-3 PUFA concentrations compared to the low-fat diet.", "population_specificity": "Lactating CD-1 mice and their offspring.", "effective_dosage": "12% high-linoleic-acid oil (HLA) or 12% saturated oil (SAT) added to diets.", "study_duration": "5 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:05.789052+00:00"}
{"study_id": 29244, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Omega-6 Fatty Acids (O6-PUFA) could reduce cancer-related fatigue (CRF) in breast cancer survivors compared to Omega-3 Fatty Acids (O3-PUFA).", "results_summary": "O6-PUFA supplementation significantly reduced CRF scores compared to O3-PUFA, with the largest benefit observed in participants with severe baseline fatigue. O6-PUFA also significantly decreased proinflammatory markers in the TNF-\u03b1 signaling pathway.", "population_specificity": "Breast cancer survivors 4-36 months posttreatment with a CRF score of \u22654/10.", "effective_dosage": "6 g/day of soybean oil (O6-PUFA).", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:06.316805+00:00"}
{"study_id": 29245, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the association of plasma and erythrocyte \u03c9-6 fatty acids with oxidative stress biomarkers in breast cancer patients.", "results_summary": "Plasma and erythrocyte \u03c9-6 fatty acids showed positive associations with anti-inflammatory and antioxidant factors, respectively, while the \u03c9-6/\u03c9-3 ratio in plasma was inversely associated with the anti-inflammatory factor.", "population_specificity": "Ninety-five women with recently diagnosed breast cancer and no previous treatment.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:07.295565+00:00"}
{"study_id": 29246, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the therapeutic potential of omega-6 fatty acids by examining their effects on antioxidant markers and matrix metalloproteinases (MMPs) in a coronary heart disease-induced rat model.", "results_summary": "Omega-6 fatty acids significantly reduced reactive oxygen species (ROS) and malondialdehyde (MDA) while increasing antioxidant enzyme activities (SOD, catalase, Gpx, AChE). They also downregulated MMP-2 and MMP-9 mRNA and protein expression in coronary heart disease-induced rats.", "population_specificity": "Coronary heart disease-induced rats", "effective_dosage": "0.5 g/kg bwt and 1 g/kg bwt", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:12.685427+00:00"}
{"study_id": 29249, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the association of heavy alcohol consumption with changes in Omega-6 and Omega-3 fatty acid levels and their inflammatory effects in alcohol-dependent patients without clinical liver injury.", "results_summary": "The study found a pro-inflammatory shift in the Omega-6:Omega-3 ratio, particularly in females with mild liver injury, and noted sex-based differences in fatty acid responses to heavy drinking. Males showed increased DHA and EPA levels, while females had lower DHA and no comparable rise in EPA.", "population_specificity": "114 heavy-drinking alcohol-dependent patients (aged 21-65) without clinical liver injury, grouped by ALT levels.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:13.758865+00:00"}
{"study_id": 29248, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "To evaluate the efficacy of omega-3 and omega-6 fatty acid supplementation for treating dry eye syndrome (DES).", "results_summary": "The study found modest improvements in tear function parameters (e.g., TBUT, Schirmer's test) and subjective symptoms (e.g., OSDI, DESS) in some trials, but evidence was insufficient to strongly recommend omega-3 and omega-6 as standalone DES treatments.", "population_specificity": "2591 patients with dry eye syndrome across fifteen studies.", "effective_dosage": "Not specified (different proportions of omega-3 and omega-6 were used).", "study_duration": "Not specified (studies published between 2005-2015).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:13.848198+00:00"}
{"study_id": 29247, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of caloric restriction on erythrocyte lipid composition, particularly omega-6 fatty acids, and compare these changes with skeletal muscle fatty acid profiles.", "results_summary": "Caloric restriction significantly modified erythrocyte fatty acid composition, particularly omega-6 fatty acids, and showed positive correlations with skeletal muscle fatty acids for monounsaturated, polyunsaturated, and omega-6 fatty acids, but not for saturated or omega-3 fatty acids.", "population_specificity": "11 healthy men, athletes in post-exercise conditions", "effective_dosage": "Not specified", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:14.120083+00:00"}
{"study_id": 29252, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 65, "study_goal": "The researchers aimed to determine whether increasing or decreasing omega-6 fatty acid intake affects cardiovascular disease (CVD) risk factors or clinical events.", "results_summary": "The study found no statistically significant effects of increased or decreased omega-6 intake on CVD risk factors like blood lipids and blood pressure, and no data on clinical CVD events. Very few trials with small participant numbers were identified.", "population_specificity": "Healthy adults or adults at high risk of CVD.", "effective_dosage": "Not specified", "study_duration": "At least six months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:14.886451+00:00"}
{"study_id": 29253, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to assess the role of Omega-6 Fatty Acids in relation to psychiatric distress, particularly how increased Omega-6 levels correlate with depressive symptoms when fish consumption decreases.", "results_summary": "The study found that higher Omega-6 levels, coupled with reduced fish intake, elevate the risk of clinical depressive symptoms. It also highlights that rebalancing fatty acid compositions toward Mediterranean diet patterns may reduce psychiatric distress.", "population_specificity": "Military personnel (implied by context, though not explicitly stated).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:15.399229+00:00"}
{"study_id": 29251, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to characterize the effects of omega-3/6 fatty acids on the STAT6 signaling pathway involved in IgE production in allergic individuals.", "results_summary": "The study found that DHA, EPA, and DPA decreased SEAP secretion (a proxy for IgE production), while AA increased it, confirming their respective inhibitory and stimulatory roles in IL-4R/IL-13R signaling. The results were statistically significant, supporting the hypothesis.", "population_specificity": "In vitro HEK-Blue IL-4/IL-13 reporter cell line model (not human subjects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:15.776859+00:00"}
{"study_id": 29250, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the association between dietary ratios of \u03c9-6/\u03c9-3 PUFAs and muscle mass in diabetic patients undergoing hemodialysis.", "results_summary": "A higher dietary ratio of \u03c9-6/\u03c9-3 PUFAs was associated with reduced muscle mass in hemodialysis patients, while adequate intake of \u03c9-3 PUFAs correlated with higher muscle mass.", "population_specificity": "69 diabetic patients undergoing hemodialysis (average age 63.0 \u00b1 10.4 years).", "effective_dosage": "Not specified for \u03c9-6 PUFAs; AI for \u03c9-3 PUFAs was 1.6 g/d (male) and 1.1 g/d (female).", "study_duration": "Cross-sectional study (no intervention duration specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:16.577979+00:00"}
{"study_id": 29256, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the differential health effects of n-6 fatty acids on cardiovascular disease outcomes, focusing on recent human epidemiological and interventional studies.", "results_summary": "The study found mixed evidence regarding n-6 fatty acids' impact on CVD outcomes, with effects varying within the n-6 series and influenced by ethnicity and background health status. Data from developing countries were sparse, highlighting the need for further research.", "population_specificity": "Human populations, with noted variability by ethnicity and health status.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:22.198349+00:00"}
{"study_id": 29258, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the potential of Omega-6 fatty acids (PUFAs) in reducing osteoarthritis symptoms and inflammation, as well as their role in decreasing reliance on NSAIDs.", "results_summary": "Omega-6 fatty acids, particularly EPA, demonstrated anti-inflammatory effects, inhibited catabolic processes, and stimulated anabolic processes in joint cartilage, effectively reducing osteoarthritis symptoms and potentially lowering the need for NSAIDs.", "population_specificity": "Patients with osteoarthritis (OA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:22.366728+00:00"}
{"study_id": 29257, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to explore the role of omega-6 fatty acids in improving lipid profiles and their potential effects on cardiovascular disease and diabetes-related complications.", "results_summary": "The abstract indicates that omega-6 fatty acids may improve lipid profiles in healthy individuals and type 2 diabetic patients, but their overall role remains largely unknown. No significant effects on glucose control, hypertension, or microvascular complications were noted.", "population_specificity": "Primarily type 2 diabetic patients, with a noted need for future research on type 1 diabetic patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:23.598051+00:00"}
{"study_id": 29260, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "To determine if oral supplementation with omega-3 and omega-6 fatty acids reduces inflammatory marker HLA-DR expression in patients with dry eye syndrome (DES).", "results_summary": "The study found a significant reduction in HLA-DR-positive cells and fluorescence intensity in the fatty acids group, suggesting anti-inflammatory effects. While no significant difference was observed in symptoms and signs, there was a tendency toward improvement in the treatment group.", "population_specificity": "Adults with mild to moderate dry eye syndrome in France and Italy.", "effective_dosage": "Three capsules daily (specific omega-6 content not detailed).", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:24.098044+00:00"}
{"study_id": 29255, "supplement_id": 1397, "safety_score": "100", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess whether interventions containing Omega-6 fatty acids, combined with other components, could reduce disease activity and disability progression in patients with relapsing-remitting multiple sclerosis.", "results_summary": "The PLP10 intervention (containing Omega-6 fatty acids) significantly reduced the annualized relapse rate by 64% and decreased the risk of sustained disability progression by 86% compared to placebo, with no reported adverse events. Interventions A and C showed no significant efficacy.", "population_specificity": "Patients aged 18-65 with relapsing-remitting MS (EDSS score 0.0-5.5), excluding those with recent relapses, immunosuppressant use, or other severe conditions.", "effective_dosage": "Administered orally once daily, 30 minutes before dinner (specific amounts not detailed).", "study_duration": "30 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:24.299640+00:00"}
{"study_id": 29261, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of high-fat diets rich in omega-6 fatty acids versus omega-3 fatty acids on UVB-induced skin carcinogenesis in mice.", "results_summary": "The study found that a high-fat diet rich in omega-6 fatty acids (HFML) was associated with higher tumor multiplicity, larger tumor sizes, and increased levels of proinflammatory cytokines compared to a diet rich in omega-3 fatty acids (HFFO). Omega-6 fatty acids appeared to promote UVB-induced skin carcinogenesis more than omega-3 fatty acids.", "population_specificity": "SKH-1 mice exposed to UVB radiation.", "effective_dosage": "Not specified (high-fat diet composition described, but exact dosage not provided).", "study_duration": "39 weeks (UVB exposure twice weekly).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:26.572213+00:00"}
{"study_id": 29259, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effect of fullerene (C(60)) on carp brain cells pre-treated with omega-6 fatty acids (linoleic acid, LA) and omega-3 fatty acids (DHA), focusing on oxidative stress markers.", "results_summary": "Pre-treatment with omega-6 (LA) and omega-3 (DHA) reduced reactive oxygen species (ROS) and thiobarbituric acid reactive substances (TBARS) in carp brain cells, with fullerene (C(60)) showing antioxidant effects. Glutathione (GSH) levels increased in some groups exposed to C(60), suggesting modulation of antioxidant pathways.", "population_specificity": "Carp brain cells (Cyprinus carpio, Cyprinidae)", "effective_dosage": "Pre-treatment with PUFA for 48 hours, followed by C(60) exposure for 2 hours (specific concentrations not provided)", "study_duration": "48 hours (PUFA pre-treatment) + 2 hours (C(60) exposure)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:28.119321+00:00"}
{"study_id": 29262, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine how Omega-6 Fatty Acids (specifically arachidonic acid, AA) influence tumor cell migration in malignant gliomas via FABP7.", "results_summary": "AA-bound FABP7 stimulated cell migration in U87 MG cells by activating cyclooxygenase-2 and reducing peroxisome proliferator-activated receptor \u03b3 levels, contrasting with DHA's inhibitory effects. The study suggests AA may promote tumor infiltration, worsening prognosis.", "population_specificity": "U87 malignant glioma cell lines.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:30.633489+00:00"}
{"study_id": 29263, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether omega-6 fatty acids could protect Ppt1-deficient neurons and neuroprogenitor cells from oxidative stress and apoptosis in a model of infantile neuronal ceroid lipofuscinosis (INCL).", "results_summary": "The study found that omega-6 fatty acids, along with omega-3, protected Ppt1-deficient cells from ER- and oxidative stress and suppressed apoptosis, suggesting potential neuroprotective effects in INCL.", "population_specificity": "Cultured neurons and neuroprogenitor cells from mice lacking Ppt1, modeling INCL.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:30.678095+00:00"}
{"study_id": 29266, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the interactions between omega-6 fatty acids (LA) and IGF signal transduction pathways and their impact on colon cancer cell survival and proliferation.", "results_summary": "The study found that LA enhanced IGF-IR phosphorylation and downstream signaling molecules (Akt, Erk), suggesting a potential mitogenic effect on HCT116 cells, reducing apoptotic activity.", "population_specificity": "Colon cancer cells (HCT116 cell line)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:32.383676+00:00"}
{"study_id": 29264, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "To evaluate the theoretical rationale and effectiveness of omega-3 and omega-6 fatty acids in treating ADHD symptoms.", "results_summary": "Some RCTs showed no improvement in ADHD symptoms, while others reported reductions, particularly in children with inattentive ADHD or comorbid conditions. The evidence remains inconclusive, and the treatment is not currently recommended as evidence-based.", "population_specificity": "Children with ADHD, including those with inattentive type and comorbid problems.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:32.672704+00:00"}
{"study_id": 29267, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess the effectiveness of omega-3/6 fatty acids in reducing ADHD symptoms in children and adolescents.", "results_summary": "A majority did not respond to omega-3/6 treatment, but a subgroup (26%) showed significant symptom reduction. After 6 months, 47% of participants exhibited meaningful improvement, particularly those with inattentive ADHD and comorbid neurodevelopmental disorders.", "population_specificity": "Children and adolescents (8-18 years) with ADHD.", "effective_dosage": "Not specified", "study_duration": "6 months (3-month placebo-controlled phase followed by 3-month open-label phase)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:35.186996+00:00"}
{"study_id": 29265, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate how Omega-6 fatty acids (specifically linoleic acid) and other polyunsaturated fatty acids regulate stearoyl-CoA desaturase (SCD) activity and influence serum triglyceride levels.", "results_summary": "The study found that linoleic acid (LA) and eicosapentaenoic acid (EPA) significantly reduced SCD mRNA levels and sterol response element binding protein-1c mRNA, correlating with lower serum triglycerides, while \u03b1-linolenic acid (ALA) did not show the same effect. The SCD index was strongly correlated with serum triglyceride levels, suggesting a regulatory role for these fatty acids in lipid metabolism.", "population_specificity": "23 subjects in a controlled clinical setting and Hep G2 cells in vitro.", "effective_dosage": "Not specified for human subjects; in vitro EC50 for LA was 0.50\u03bcM and for EPA was 1.67\u03bcM.", "study_duration": "6 weeks per diet in a crossover study; 24-hour incubations for Hep G2 cells.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:36.873414+00:00"}
{"study_id": 29268, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of topical alpha-linolenic acid (ALA) and linoleic acid (LA) in treating dry eye signs and inflammatory changes in a mouse model.", "results_summary": "Topical ALA significantly reduced corneal fluorescein staining, CD11b(+) cell number, and inflammatory cytokine expression (IL-1alpha, TNF-alpha) in dry eye-induced mice. LA effects were not highlighted, but ALA demonstrated anti-inflammatory and therapeutic benefits.", "population_specificity": "Mice with induced dry eye syndrome.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:37.420635+00:00"}
{"study_id": 29269, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the effect of two different enteral supplements (Impact\u00ae Powder Extra and Standard) on leptin levels and nutritional status in Crohn's disease patients during prednisolone treatment.", "results_summary": "Both supplements improved leptin levels, BMI, and total cholesterol by week 5, though leptin increases were transient due to prednisolone withdrawal. Clinical and biochemical markers improved, but triglyceride levels increased significantly in the Standard group.", "population_specificity": "31 Crohn's disease patients with active disease undergoing prednisolone treatment.", "effective_dosage": "Not specified", "study_duration": "9 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:39.476930+00:00"}
{"study_id": 29272, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "To assess the effects of omega-6 fatty acids (6-Impact Powder) as adjuvant therapy on proinflammatory and anti-inflammatory cytokine profiles in patients with active Crohn's disease.", "results_summary": "The 6-Impact Powder group showed significant changes in concentrations of multiple cytokines (interleukin-1beta, interleukin-6, interferon-gamma, monocyte chemoattractant protein-1, interleukin-2, interleukin-4, interleukin-5, and interleukin-10), indicating a broader immunomodulatory effect compared to omega-3 fatty acids.", "population_specificity": "31 patients with active Crohn's disease.", "effective_dosage": "Not specified.", "study_duration": "9 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:42.058954+00:00"}
{"study_id": 29270, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to assess the effect of a high-fat diet rich in omega-6 fatty acids on colon carcinogenesis and inflammatory response in rats, and whether quercetin or beta-carotene supplementation could mitigate these effects.", "results_summary": "A high-fat diet rich in omega-6 fatty acids increased aberrant crypt foci (ACF) formation and upregulated iNOS expression but did not significantly affect COX-2 expression or PGE2 levels. Quercetin and beta-carotene reduced ACF formation in high-fat diet-fed rats but did not significantly impact tumor incidence or inflammatory markers.", "population_specificity": "Rats exposed to azoxymethane (AOM)-induced colon carcinogenesis.", "effective_dosage": "Not specified for omega-6 fatty acids; quercetin or beta-carotene supplementation details not provided.", "study_duration": "Sacrificed at 8 weeks (ACF assessment) and 33 weeks (tumor assessment) after last AOM treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:42.061978+00:00"}
{"study_id": 29271, "supplement_id": 1397, "safety_score": "20", "efficacy_score": 10, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of omega-6 fatty acids (specifically arachidonic acid) versus omega-3 fatty acids on outcomes after spinal cord injury in rats.", "results_summary": "The study found that treatment with arachidonic acid (an omega-6 PUFA) significantly worsened outcomes after spinal cord injury compared to controls, including poorer locomotor performance and increased damage. In contrast, omega-3 PUFAs showed neuroprotective effects.", "population_specificity": "Rats with induced spinal cord injury (lateral hemisection or compression injury).", "effective_dosage": "Not specified for omega-6 PUFAs (timing: injected 30 min after injury).", "study_duration": "Effects monitored up to 6 weeks post-injury.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:42.083639+00:00"}
{"study_id": 29254, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine how different ratios of omega-6 to omega-3 fatty acids in diets affect allergic reactions and immune responses in mice sensitized to cow \u03b2-lactoglobulin.", "results_summary": "Omega-6-rich diets (O6H) showed no allergy alleviation and promoted a stronger Th2 immune response, while omega-3-rich diets (O3H and O3O6) reduced allergic severity and favored a Th1 immune response. O6H mice exhibited higher IL-4 levels and lower rectal temperatures post-challenge compared to omega-3-fed groups.", "population_specificity": "Three-week-old Balb/c mice (n=20/group).", "effective_dosage": "Not specified (dietary ratios: O6H = 10:1, O3O6 = 4:1, O3H = 1:4 omega-6 to omega-3).", "study_duration": "6 weeks (from 3 to 9 weeks of age).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:44.916324+00:00"}
{"study_id": 29274, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of individual omega-6 fatty acids on preventing chemically induced diabetes mellitus in experimental animals.", "results_summary": "Prior exposure to linoleic acid, gamma-linolenic acid, and arachidonic acid prevented alloxan-induced cytotoxicity and apoptosis in insulin-secreting cells, with gamma-linolenic acid and arachidonic acid also restoring antioxidant status and normalizing fatty acid concentrations in plasma phospholipids.", "population_specificity": "Insulin-secreting rat insulinoma cell line (RIN) and experimental animals (rats).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:45.658541+00:00"}
{"study_id": 29275, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of omega-6 fatty acids (specifically arachidonic acid, AA) on tumorigenesis, particularly their role in promoting skin cancer risk and their interaction with omega-3 fatty acids.", "results_summary": "The study found that AA did not directly affect TPA- or EGF-induced AP-1 transactivation or cell transformation but abrogated the inhibitory effects of DHA (an omega-3 fatty acid) on these processes in a dose-dependent manner. This suggests that omega-6 fatty acids may counteract the protective effects of omega-3 fatty acids against tumorigenesis.", "population_specificity": "Mouse epidermal JB6 cells", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "AA counteracted the inhibitory effects of DHA on TPA- and EGF-induced AP-1 transactivation and cell transformation.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:48.311025+00:00"}
{"study_id": 29276, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether polyunsaturated omega-6 fatty acids (e.g., arachidonic acid) share the cytotoxic activity of docosahexaenoic acid (22:6) in tumor cells.", "results_summary": "The study found that cytotoxicity is unique to 22:6-containing phosphatidylcholine (PC) and not shared by PCs with other polyunsaturated omega-3 or omega-6 fatty acids, including arachidonic acid (20:4). Omega-6 fatty acids were taken up by cells but did not exhibit cytotoxic effects.", "population_specificity": "Cultured T27A murine leukemia cells (in vitro study).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:48.813666+00:00"}
{"study_id": 29278, "supplement_id": 1397, "safety_score": "90", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to compare the blood pressure-lowering effects of omega-6 fatty acids (from corn oil) versus omega-3 fatty acids (from fish oil) in elderly hypertensive subjects.", "results_summary": "The study found no significant between-group differences in blood pressure changes between omega-6 and omega-3 supplements, though both lowered blood pressure within groups. Omega-6 (corn oil) showed a modest reduction in standing DBP compared to baseline, but the effect was less pronounced than with fish oil.", "population_specificity": "Elderly hypertensive subjects (aged \u226560 years) with SBP \u2265160 or DBP \u226590 mm Hg.", "effective_dosage": "9 g corn oil per day (omega-6 fatty acids).", "study_duration": "Two 8-week treatment periods separated by a 3-week washout.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:51.764453+00:00"}
{"study_id": 29279, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of omega-6 fatty acids (from corn oil) and omega-3 fatty acids (from menhaden oil) during the initiation and postinitiation stages of colon carcinogenesis in rats.", "results_summary": "High corn oil (HCO) diet during the postinitiation phase increased colon tumor incidence and multiplicity, while high menhaden oil (HFO) diet reduced these effects. The HCO diet during the initiation phase had no significant impact on carcinogenesis.", "population_specificity": "Male F344 rats", "effective_dosage": "5% corn oil (LCO), 23.5% corn oil (HCO), or 18.5% menhaden oil plus 5% corn oil (HFO)", "study_duration": "42 weeks after carcinogen treatment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:52.566143+00:00"}
{"study_id": 29277, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to investigate the effects of omega-6 fatty acids (linoleic acid) on prostate cancer cell proliferation in various cell lines.", "results_summary": "Linoleic acid (omega-6) promoted cell growth in all tested cell lines except EPYP1. The study also found that low concentrations of omega-3 fatty acids (EPA) promoted growth in human prostate cancer cell lines, while higher concentrations inhibited growth.", "population_specificity": "Human metastatic (PC-3, LNCaP, TSU) and rat metastatic (Mat-Ly-Lu) prostate cancer cell lines, as well as rat non-metastatic epithelial cell lines (EPYP1, EPYP2, EPYP3).", "effective_dosage": "1-100 ng/ml for linoleic acid; 1 ng/ml for EPA (low concentration).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:52.992672+00:00"}
{"study_id": 29280, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine how varying the ratio of dietary omega-3 to omega-6 fatty acids affects the development of pancreatic preneoplastic lesions in rats.", "results_summary": "Increasing the omega-3 to omega-6 ratio significantly reduced preneoplastic lesion development and lowered serum prostaglandin levels. Dietary intervention with omega-3-rich fats decreased lesion formation, while omega-6-rich fats increased it.", "population_specificity": "Male Wistar rats given azaserine at 14 days of age.", "effective_dosage": "Diet totaling 20% by weight of fat (specific omega-3 to omega-6 ratios not detailed).", "study_duration": "4 months post-dosing (with dietary intervention at 2 months in the second experiment).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:54.580709+00:00"}
{"study_id": 29273, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of omega-3 and omega-6 fatty acids as adjuvant enteral nutrition on the GH/IGF-I axis in patients with Crohn's disease.", "results_summary": "The study found no significant differences between omega-3 and omega-6 fatty acids in their effects on the GH/IGF-I axis. Both groups showed increases in tIGF-I, fIGF-I, and IGFBP-3, likely due to corticosteroid treatment rather than the fatty acids.", "population_specificity": "31 patients with active Crohn's disease (CDAI: 186-603).", "effective_dosage": "Omega-6-FA, 9 g/day.", "study_duration": "9 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:54.637845+00:00"}
{"study_id": 29281, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of varying dietary levels of omega-6 fatty acids (from corn oil) and omega-3 fatty acids (from Menhaden oil) on colon carcinogenesis in rats.", "results_summary": "High-fat diets with higher omega-3 and lower omega-6 fatty acids significantly reduced the incidence and multiplicity of colon adenocarcinomas compared to high omega-6 diets. Omega-6 fatty acids were associated with increased tumor incidence and higher colonic mucosal ornithine decarboxylase activity.", "population_specificity": "Male F344 rats", "effective_dosage": "Various combinations of corn oil (5%, 11.8%, 17.6%, 23.5%) and Menhaden oil (1%, 5.9%, 11.8%, 17.6%)", "study_duration": "38 weeks after carcinogen treatment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:56.348785+00:00"}
{"study_id": 194478, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to assess the effects of polyunsaturated fatty acids (PUFAs), including Omega-6 Fatty Acids, on lipid profiles (LDL, HDL, and LDL/HDL ratio) in patients undergoing renal replacement therapy (RRT).", "results_summary": "The study conducted a network meta-analysis of 28 RCTs but reported ambiguous results due to mixed reports of various nutrients used in interventions. The effects of PUFAs on lipid profiles in RRT patients were not conclusively determined.", "population_specificity": "Patients receiving renal replacement therapy (RRT).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:57.727239+00:00"}
{"study_id": 194479, "supplement_id": 1397, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of omega-3 and omega-6 fatty acid supplementation on erythrocyte fatty acid levels and cytokine profiles in children recently diagnosed with Autism Spectrum Disorder (ASD).", "results_summary": "The study found that omega-3 and omega-6 supplementation increased erythrocyte fatty acid levels (EPA and DHA) and reduced IL-2 cytokine levels compared to placebo. The treatment was tolerable with adherence greater than 70%.", "population_specificity": "Children aged 2 to under 6 years recently diagnosed with Autism Spectrum Disorder (ASD).", "effective_dosage": "Daily oral supplement based on participant weight (specific amounts not detailed in the abstract).", "study_duration": "90 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:58.054720+00:00"}
{"study_id": 194480, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine the long-term effects of omega-6 fatty acids on inflammatory bowel diseases (IBD) and inflammatory markers.", "results_summary": "The study found sparse outcomes for omega-6 fatty acids, suggesting little or no effect on IBD prevention, treatment, or inflammatory markers where data were available.", "population_specificity": "Adults with or without IBD (41,751 participants, including 13 RCTs with IBD participants).", "effective_dosage": "Not specified", "study_duration": "\u2265 24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:59.015949+00:00"}
{"study_id": 194484, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the effects of different combinations of omega-3 and omega-6 fatty acids on dry eye syndrome (DES) in long-term contact lens wearers, with or without topical cyclosporine.", "results_summary": "A properly balanced combination of omega-3 and omega-6 fatty acids significantly alleviated contact lens-related DES. Topical cyclosporine further reduced cytokine production and improved DES symptoms.", "population_specificity": "360 long-term contact lens wearers with dry eye syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:00.886673+00:00"}
{"study_id": 194482, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to determine whether omega-3 and -6 fatty acid supplementation could improve language development in children at risk for autism spectrum disorder (ASD).", "results_summary": "The study found that gesture use, but not word production, increased more in children receiving omega-3 and -6 supplementation compared to the placebo group, suggesting possible effectiveness for language development in at-risk children.", "population_specificity": "Children at risk for ASD (n=31).", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:01.451147+00:00"}
{"study_id": 194485, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness of omega-6 fatty acids, specifically gamma linolenic acid, in the prevention or treatment of atopic dermatitis.", "results_summary": "The study found that gamma linolenic acid (an omega-6 fatty acid) was unsuccessful in preventing or treating atopic dermatitis, while omega-3 fatty acids showed potential promise in preventing allergic disorders, particularly atopic dermatitis. Further randomized controlled studies are needed to confirm these effects.", "population_specificity": "Not specified (general human nutrition context).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:03.186573+00:00"}
{"study_id": 194488, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 1, "quality_score": 20, "study_goal": "To assess the effects of polyunsaturated fatty acids (PUFAs), including omega-6 fatty acids, on learning outcomes in children with specific learning disorders.", "results_summary": "The study found no suitable trials for inclusion, concluding there is insufficient evidence to support or refute the use of PUFAs for children with specific learning disorders.", "population_specificity": "Children aged below 18 years with specific learning disabilities diagnosed using DSM-IV, ICD-10, or equivalent criteria, including those with co-existing developmental disorders like ADHD or autism.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:05.583889+00:00"}
{"study_id": 194491, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the potential of omega-6 fatty acids as an adjunctive treatment for dry eye disease, focusing on their anti-inflammatory effects and symptom relief.", "results_summary": "Omega-6 fatty acids showed efficacy in alleviating dry eye symptoms, likely due to their anti-inflammatory properties, though further research is needed to standardize treatment protocols.", "population_specificity": "Patients with dry eye disease.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:06.663294+00:00"}
{"study_id": 194489, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 60, "study_goal": "The researchers aimed to determine whether Omega-6 fatty acids (specifically linoleic acid) could improve disease progression or relapse outcomes in multiple sclerosis (MS) patients.", "results_summary": "Omega-6 fatty acids (11-23 g/day linoleic acid) showed no significant benefit in disease progression for MS patients. Some studies suggested slight potential benefits in relapse outcomes, but these findings were limited by poor endpoint validity.", "population_specificity": "144 MS patients (general) and 65 chronic progressive MS patients.", "effective_dosage": "11-23 g/day linoleic acid (general MS), 2.9-3.4 g/day linoleic acid (chronic progressive MS).", "study_duration": "24 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:07.016662+00:00"}
{"study_id": 194490, "supplement_id": 1397, "safety_score": "80", "efficacy_score": 30, "quality_score": 70, "study_goal": "The researchers aimed to determine whether postoperative administration of \u03c9-3 and \u03c9-6 fatty acids improves cellular hypoperfusion and lactate clearance in patients undergoing major gastric surgery.", "results_summary": "The study found no significant differences in serum lactate levels, complication rates, biochemical parameters, hospital stay, or mortality between patients receiving \u03c9-3 and \u03c9-6 fatty acids versus \u03c9-6 fatty acids alone.", "population_specificity": "Patients undergoing gastric cancer surgery (n=26).", "effective_dosage": "Omegaven (0.2 g/kg/d) + Lipovenoes 10% (0.6 g/kg/d) for the intervention group; Lipovenoes 10% (0.8 g/kg/d) for the control group.", "study_duration": "5 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:08.015545+00:00"}
{"study_id": 194492, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the relationship between adipokines (leptin and adiponectin) and omega-6 fatty acids (n-6FA) in patients with end-stage renal disease (ESRD).", "results_summary": "The study found an inverse association between plasma adiponectin and erythrocyte n-6FA in hemodialysis patients, suggesting n-6FA may promote inflammation. Leptin levels were positively associated with BMI and cholesterol but not directly linked to n-6FA effects.", "population_specificity": "44 hemodialysis patients, 29 peritoneal dialysis patients, and 10 healthy controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:10.069343+00:00"}
{"study_id": 29447, "supplement_id": 1398, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to compare the effects of a 10-day vegan diet versus an isocaloric, isonitrogenous omnivorous diet on daily mixed muscle protein synthesis (MPS) rates in older adults.", "results_summary": "The study found no significant difference in MPS rates between the vegan and omnivorous diets. The omnivorous diet resulted in higher plasma cholesterol levels (LDL, HDL, and total cholesterol) compared to the vegan diet, but no differences were observed in other cardiometabolic markers.", "population_specificity": "Community-dwelling older adults (72 \u00b1 4 years, 18 males, 16 females).", "effective_dosage": "Not specified beyond dietary composition (60% animal protein in omnivorous diet).", "study_duration": "10 days per diet (cross-over design).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:11.945288+00:00"}
{"study_id": 29448, "supplement_id": 1398, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the effects of an exclusively plant-based protein diet versus a mixed diet on muscle mass and strength gains in young men undergoing resistance training.", "results_summary": "Both plant-based and mixed diets resulted in similar significant increases in leg lean mass, muscle cross-sectional area, and strength, with no statistically significant differences between the groups. The study concluded that protein source does not affect resistance training-induced adaptations when protein intake is adequate.", "population_specificity": "Healthy young men (19 vegans and 19 omnivores, aged 26 \u00b1 5 years).", "effective_dosage": "1.6 g kg-1 day-1 of protein, adjusted via supplemental protein (soy for vegans, whey for omnivores).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:12.651036+00:00"}
{"study_id": 194493, "supplement_id": 1398, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to compare the health status of omnivorous endurance runners (OR) with vegetarian (VER) and vegan endurance runners (VGR).", "results_summary": "The study found significant differences in health-related indicators and behaviors among OR, VER, and VGR, but specific outcomes for omnivorous diets were not detailed in the abstract.", "population_specificity": "245 female and male recreational endurance runners (109 OR, 45 VER, 91 VGR).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:14.695404+00:00"}
{"study_id": 27516, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 82, "study_goal": "The researchers aimed to assess the accuracy of ChatGPT as an educational resource for parents of children undergoing Oral Immunotherapy (OIT).", "results_summary": "ChatGPT provided intelligible and comprehensive responses to common OIT-related questions, with healthcare practitioners rating its answers positively (average median rankings of 8.6, 8.4, and 7.8 for basic, advanced, and medical categories, respectively). However, readability was low, and understandability was reduced due to response complexity.", "population_specificity": "Parents of children undergoing OIT.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:14.923851+00:00"}
{"study_id": 29450, "supplement_id": 1398, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to compare the health effects of a traditional Daniel Fast (restricted vegan), a modified Daniel Fast (restricted omnivorous), and an unrestricted vegan diet on anthropometric and biochemical measures.", "results_summary": "The modified DF (omnivorous) showed a 10% decrease in total and LDL cholesterol, a 5 mmHg reduction in systolic BP, and a 2 mmHg reduction in diastolic BP, but no significant changes in insulin or oxidative stress markers compared to the traditional DF.", "population_specificity": "35 subjects (6 men, 29 women) aged 18-67 years.", "effective_dosage": "Ad libitum meat and skim milk consumption (modified DF).", "study_duration": "21 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:15.895906+00:00"}
{"study_id": 194486, "supplement_id": 1397, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether omega-3 fatty acid supplementation could reduce inflammation and blood cell adhesion in patients with sickle cell disease (SCD).", "results_summary": "The study found that omega-3 supplementation increased DHA and EPA levels, reduced white blood cell count and monocyte integrin, and lowered NF-\u03baB gene expression, suggesting anti-inflammatory effects. However, no significant changes were observed in other inflammatory markers like C-reactive protein or cytokines.", "population_specificity": "Homozygous SCD patients (HbSS) aged 5-16 years, compared with healthy controls (HbAA).", "effective_dosage": "Two or three capsules daily containing 277.8 mg DHA and 39.0 mg EPA, adjusted by age group (5-10 or 11-16 years).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:15.936684+00:00"}
{"study_id": 27517, "supplement_id": 1399, "safety_score": "70", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of peanut oral immunotherapy (OIT) in peanut-allergic adults using real-world peanut products.", "results_summary": "67% of participants achieved the primary endpoint of tolerating a cumulative dose of 1.4 g peanut protein, with a 100-fold increase in median tolerated dose. OIT also improved quality of life and showed immunological changes, though three participants withdrew due to adverse reactions.", "population_specificity": "Peanut-allergic adults (mean age 24.2 years, 8 female).", "effective_dosage": "Maintenance dose of 1000 mg (four large peanuts) daily, with updosing every two weeks.", "study_duration": "Not explicitly stated, but updosing occurred every two weeks until maintenance.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:17.516400+00:00"}
{"study_id": 27518, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate how different definitions of dose \"tolerance\" impact reported desensitization rates in food allergen immunotherapy (AIT).", "results_summary": "The study found that using less objective symptoms to define dose tolerance can overestimate food-AIT efficacy by 15%, suggesting that more patient-centric outcomes may improve outcome harmonization in clinical trials.", "population_specificity": "Patients from three randomized-controlled trials and one real-world registry.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:18.487993+00:00"}
{"study_id": 27520, "supplement_id": 1399, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and effectiveness of combining rapid food desensitization with omalizumab as an introductory step to oral immunotherapy for managing food-induced anaphylaxis.", "results_summary": "The study found that the combined strategy enhanced safety and effectiveness by reducing severe allergic reactions and improving allergen tolerance, with rapid desensitization offering time and cost savings.", "population_specificity": "Patients with food-induced anaphylaxis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:20.601750+00:00"}
{"study_id": 27519, "supplement_id": 1399, "safety_score": "75", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy and safety of omalizumab as an adjunct to Oral Immunotherapy (OIT) for IgE-mediated food allergy in children.", "results_summary": "OIT combined with omalizumab resulted in higher desensitization rates, faster allergen tolerance, and reduced adverse reactions compared to OIT alone, though long-term tolerance post-omalizumab remains uncertain.", "population_specificity": "Pediatric patients with IgE-mediated food allergy.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:20.849121+00:00"}
{"study_id": 27521, "supplement_id": 1399, "safety_score": "75", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to provide an overview of Oral Immunotherapy (OIT) and discuss its role in treating IgE-mediated food allergy, particularly in infants and toddlers.", "results_summary": "The study found that OIT is well tolerated in infants and toddlers and can lead to sustained unresponsiveness (remission) to food allergens. It recommends OIT as a treatment option for food allergy under medical supervision.", "population_specificity": "Infants and toddlers with IgE-mediated food allergy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:23.469012+00:00"}
{"study_id": 27522, "supplement_id": 1399, "safety_score": "90", "efficacy_score": 95, "quality_score": 92, "study_goal": "The researchers aimed to compare the effectiveness and safety of peanut oral immunotherapy (P-OIT) using home-measured peanut butter versus peanut avoidance in children with high-threshold peanut allergy.", "results_summary": "P-OIT significantly increased desensitization rates (100% success vs. 21% in avoidance) and sustained unresponsiveness (68.4% vs. 8.6%). No serious adverse events or reactions beyond grade 1 severity were reported.", "population_specificity": "Children aged 4 to 14 years with allergic reactions to 443 mg to 5043 mg of peanut protein.", "effective_dosage": "Home-measured peanut butter (exact dosage not specified, but challenges involved up to 9043 mg of peanut protein).", "study_duration": "16 weeks of ad lib ingestion followed by 8 weeks of abstinence for sustained unresponsiveness testing.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:25.194812+00:00"}
{"study_id": 27523, "supplement_id": 1399, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy and safety of different immunotherapy administration routes (subcutaneous, sublingual, oral) for treating allergies to various allergens.", "results_summary": "Oral immunotherapy was effective for food allergies with gastrointestinal symptoms and was noted as the only approved treatment for elderly patients due to its low risk of side effects. It was also found to be safe and effective in time-accelerated and dosage-enhanced protocols.", "population_specificity": "Patients with allergic conditions to pollen (trees, grasses, weeds), house dust mites, Alternaria alternata spores, and food allergies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:25.869713+00:00"}
{"study_id": 27525, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether age or peanut-specific IgE levels independently predict remission in children undergoing Oral Immunotherapy (OIT).", "results_summary": "Higher baseline peanut-specific IgE levels were consistently associated with lower remission likelihood, while age showed no independent association after adjustment. The study found no evidence supporting younger age as a predictor of remission following OIT.", "population_specificity": "Children aged 1-10 years who completed 18 months of OIT in the PPOIT-003 RCT (n=162).", "effective_dosage": "Not specified", "study_duration": "18 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:26.492446+00:00"}
{"study_id": 27524, "supplement_id": 1399, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to determine whether baked milk oral immunotherapy (BMOIT) could reduce adverse reactions while inducing desensitization in milk-allergic children and to identify immunological correlates of successful BMOIT.", "results_summary": "BMOIT was well tolerated, with 70% of participants tolerating 4044 mg of baked milk protein by month 24 and 36.7% tolerating 2000 mg or more of unheated milk protein. Immunological changes included increased IgG4 and Tregs and decreased IgE and Th2A cells, correlating with desensitization.", "population_specificity": "Milk-allergic children aged 3-18 years.", "effective_dosage": "4044 mg of baked milk protein (primary endpoint), 2000 mg or more of unheated milk protein (secondary endpoint).", "study_duration": "24 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:27.275693+00:00"}
{"study_id": 27526, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the cost-effectiveness of egg oral immunotherapy (OIT) compared to egg avoidance in school-age children and identify the most cost-effective age to start treatment.", "results_summary": "OIT was cost-effective when initiated at age 8 or older, with the best cost-effectiveness observed at age 12. Cost-effectiveness improved further if OIT-induced remission rates increased to ~40%. Without OIT, most children achieved natural resolution by age 24.", "population_specificity": "1,000 children aged 4 years with egg allergy.", "effective_dosage": "Not specified", "study_duration": "20-year time horizon", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:28.223720+00:00"}
{"study_id": 27527, "supplement_id": 1399, "safety_score": "70", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine whether dupilumab enhances the efficacy of oral immunotherapy (OIT) with AR101 in pediatric patients with peanut allergy.", "results_summary": "Dupilumab + OIT led to a 20.2% increase in patients passing a peanut protein challenge after up-dosing compared to OIT alone, though continuous dupilumab treatment during maintenance showed a non-significant 16.6% improvement. Safety was consistent with dupilumab's known profile, but it did not protect against OIT-related anaphylaxis.", "population_specificity": "Pediatric patients (6-17 years old) with confirmed peanut allergy.", "effective_dosage": "2044 mg (cumulative) of peanut protein during food challenges.", "study_duration": "28-40 weeks up-dosing, followed by 24-week maintenance and 12-week post-treatment follow-up.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:31.984738+00:00"}
{"study_id": 27529, "supplement_id": 1399, "safety_score": "75", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the safety and feasibility of cashew nut oral immunotherapy (OIT) compared to peanut OIT, focusing on the up-dosing process and adverse reactions.", "results_summary": "Cashew nut OIT showed lower severity of adverse reactions and better tolerability than peanut OIT, with 91% of cashew nut-allergic patients achieving desensitization compared to 73% of peanut-allergic patients. Severe reactions were rare but more common in peanut-allergic children with high baseline IgE levels.", "population_specificity": "Children with cashew nut or peanut allergies treated at the University Children's Hospital Basel between 2018 and 2022.", "effective_dosage": "Incremental increases of 20-30% every 2 weeks until reaching a maintenance dose of 1 g of nut protein.", "study_duration": "18-24 months of maintenance dose before a second oral food challenge.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:32.409717+00:00"}
{"study_id": 27530, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify metabolomic pathways associated with tolerance in food allergy and responses to oral immunotherapy (OIT), comparing sustained unresponsiveness (SU) versus transient desensitization (TD).", "results_summary": "The study found distinct metabolomic profiles involving bile acids, histidines, and eicosanoids in food allergy patients, with changes over OIT duration. Participants achieving SU had higher levels of immunomodulatory metabolites like lithocholate and urocanic acid, suggesting potential mechanisms of tolerance.", "population_specificity": "Multiethnic cohorts including healthy infants (N=384), children with asthma (N=1040), and participants in a peanut OIT trial (N=20).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:33.641035+00:00"}
{"study_id": 27532, "supplement_id": 1399, "safety_score": "30", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the potential of oral immunotherapy as an intervention to modify allergies and reduce severe reaction risks, while acknowledging its limitations and failure rates.", "results_summary": "The study found that oral immunotherapy can modify allergies but has a notable failure rate and potential for severe, life-threatening outcomes. Discontinuing therapy may increase the risk of fatal reactions, and omalizumab was suggested as an alternative for failed cases.", "population_specificity": "Not specified (general allergy patients implied).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:33.794535+00:00"}
{"study_id": 27535, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Oral Immunotherapy (OIT) improves the quality of life in adults with food allergies compared to non-OIT controls.", "results_summary": "OIT significantly improved quality of life in adults with food allergies, with 75% achieving full desensitization. The study group showed statistically and clinically better scores in allergen avoidance, emotional impact, and overall quality of life compared to controls.", "population_specificity": "Adults aged \u226518 years with food allergies (milk, egg, peanut, sesame, tree nuts).", "effective_dosage": "Median starting dose of 23.8 mg protein.", "study_duration": "Median of 10.3 months to reach full desensitization.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:36.755406+00:00"}
{"study_id": 27536, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop and evaluate a pediatric decision-aid tool to support shared decision-making regarding oral immunotherapy (OIT) initiation versus allergen avoidance for food-allergic children.", "results_summary": "The decision-aid demonstrated good acceptability, high decisional self-efficacy (85.9/100), and low decisional conflict (20.9/100) among caregivers, with balanced information and no bias toward a \"best choice.\" Lower decisional conflict was linked to caregiver-reported anaphylaxis.", "population_specificity": "Caregivers of food-allergic children.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:36.902165+00:00"}
{"study_id": 27538, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy and safety of low-dose sesame protein oral immunotherapy (OIT) in pediatric patients with IgE-mediated sesame allergy, comparing it to standard treatment (elimination diet).", "results_summary": "The study protocol outlines a randomized controlled trial to assess OIT's ability to increase tolerance to sesame protein (4000 mg dose) and monitor adverse events, immunological changes, and maximum tolerated doses, but final results are not yet reported.", "population_specificity": "Pediatric patients aged 3-17 with confirmed IgE-mediated sesame allergy.", "effective_dosage": "300 mg sesame protein (maintenance dose), administered once daily.", "study_duration": "Up to 18 months (including dose escalation and 3-month maintenance phase).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:42.459541+00:00"}
{"study_id": 27537, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to characterize racial and ethnic disparities in attitudes toward, familiarity with, and utilization of oral immunotherapy (OIT) among caregivers of children with food allergies.", "results_summary": "The study found that non-Hispanic Black (NHB) and Hispanic or Latino (H/L) caregivers were significantly less familiar with OIT and less likely to have initiated it compared to non-Hispanic White (NHW) caregivers, even after adjusting for household income.", "population_specificity": "Caregivers of children with food allergies enrolled in the Food Allergy Outcomes Related to White and African American Racial Differences cohort.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:43.109741+00:00"}
{"study_id": 27540, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify fecal microbial predictors of Peanut Oral Immunotherapy (POIT) efficacy and understand mechanistic insights into treatment response.", "results_summary": "The study identified five microbial-derived bile acids enriched in fecal samples before POIT initiation that predicted treatment efficacy (AUC 0.71). POIT failure was associated with a distinct fecal microbiome with enhanced bile acid deconjugation, amino acid metabolism, and increased peanut peptide degradation.", "population_specificity": "Children (n=79) undergoing POIT in a double-blind, placebo-controlled clinical trial.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:43.113162+00:00"}
{"study_id": 27539, "supplement_id": 1399, "safety_score": "75", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the long-term outcomes, risks, and benefits of oral immunotherapy (OIT) by comparing clinical outcomes (remission, desensitization without remission, and remaining allergic) in children.", "results_summary": "The study found that remission participants had fewer reactions, less severe reactions, and greater health-related quality of life improvement compared to desensitization without remission or allergic participants. Peanut ingestion post-treatment was higher in OIT groups than placebo, and reactions reduced over time across all groups.", "population_specificity": "Children who completed the PPOIT-003 randomized trial.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Follow-up at 1-year and 2-years post-treatment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:43.844235+00:00"}
{"study_id": 27541, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to trace historical milestones in OIT and EPIT development, describe their immunologic mechanisms, and identify areas for future research.", "results_summary": "OIT and EPIT originate from AIT, differing in administration routes and shorter sustained unresponsiveness periods. Progress has been made, but many questions remain before full understanding is achieved.", "population_specificity": "Patients with food allergies (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:44.589050+00:00"}
{"study_id": 27534, "supplement_id": 1399, "safety_score": "65", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to identify the reasons for discontinuation of Oral Immunotherapy (OIT), particularly focusing on social factors and adverse effects.", "results_summary": "The study found that social factors were the most common reason for OIT discontinuation (64%), followed by adverse effects (48%) and anxiety (34%). Gastrointestinal symptoms were the most prevalent adverse effect, while anaphylaxis contributed to discontinuation in 30% of cases.", "population_specificity": "Pediatric patients aged 10 months to 18 years and 2 months, treated in community pediatric allergy practices.", "effective_dosage": "Not specified", "study_duration": "October 1, 2017, to October 27, 2022 (retrospective chart review)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:44.732836+00:00"}
{"study_id": 27533, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to understand the biological mechanisms of food allergy and oral immunotherapy (OIT) prognosis, identify predictive biomarkers, and improve OIT accessibility.", "results_summary": "The study established a biobank of biological samples and clinical data but did not report specific OIT outcomes or efficacy metrics. It highlighted an interdisciplinary effort to enhance food allergy care.", "population_specificity": "183 children with IgE-mediated food allergy and 27 non-allergic siblings from the Saguenay-Lac-Saint-Jean region, Canada.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:44.867372+00:00"}
{"study_id": 27546, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to identify practical considerations for implementing Oral Immunotherapy (OIT) in clinical practice, focusing on office setup, staffing, and logistics.", "results_summary": "The study highlights the importance of proper office setup, staffing, scheduling, and on-call responsibilities for safely and effectively integrating OIT into clinical practice, beyond just products and protocols.", "population_specificity": "Not specified", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:50.698378+00:00"}
{"study_id": 27545, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the evidence on milk oral immunotherapy (OIT), discuss key studies, and provide practical information about its use in managing cow's milk allergy (CMA).", "results_summary": "The abstract suggests that milk OIT may protect patients from accidental exposures and allow increased milk intake, but it does not provide specific efficacy or safety data. The natural history of CMA is favorable for most, but some cases persist.", "population_specificity": "Children with cow's milk allergy (CMA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:51.124099+00:00"}
{"study_id": 27544, "supplement_id": 1399, "safety_score": "60", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to outline key considerations for shared decision-making regarding Oral Immunotherapy (OIT) by discussing its risks, benefits, and uncertainties.", "results_summary": "OIT can desensitize individuals with food allergies and potentially reduce reaction severity, but it carries risks like allergic reactions, eosinophilic esophagitis, and logistical challenges, with uncertain long-term outcomes. The study emphasizes the importance of shared decision-making to align treatment with patient values and preferences.", "population_specificity": "Individuals with immunoglobulin E-mediated food allergies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:51.522431+00:00"}
{"study_id": 27549, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 40, "study_goal": "The researchers aimed to review the challenges and current state of oral immunotherapy (OIT) for fish and shellfish allergies, including practical and immunologic barriers.", "results_summary": "The abstract highlights that seafood OIT faces multiple challenges, such as taste, odor, cross-reactivity issues, and protein concentration changes during cooking, but suggests that motivated patients may benefit under experienced supervision.", "population_specificity": "Patients with fish and shellfish allergies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:52.561544+00:00"}
{"study_id": 27547, "supplement_id": 1399, "safety_score": "75", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the safety and efficacy of tree nut oral immunotherapy (TN-OIT) as a treatment option for patients with tree nut allergy.", "results_summary": "The study found that TN-OIT is reasonably safe and effective, with clinical cross-reactivity noted between certain tree nuts. Nonpharmaceutical food products were identified to facilitate dosing.", "population_specificity": "Patients with tree nut allergy, particularly those with persistent allergy and confirmed sensitization via skin-prick or serum IgE testing.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:52.636886+00:00"}
{"study_id": 27548, "supplement_id": 1399, "safety_score": "60", "efficacy_score": null, "quality_score": 70, "study_goal": "The researchers aimed to describe common adverse events in Oral Immunotherapy (OIT), review their frequency and risk factors, and discuss treatment strategies to ensure patient safety and tolerability.", "results_summary": "The abstract highlights that OIT can cause a range of adverse events, from mild oral reactions to severe systemic reactions requiring epinephrine, and emphasizes the need for allergists to understand these reactions for safe administration.", "population_specificity": "Not specified (focus on real-world reports from private practice).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:54.077419+00:00"}
{"study_id": 27542, "supplement_id": 1399, "safety_score": "65", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy, safety, and limitations of oral immunotherapy (OIT) for food allergies, including its potential to induce desensitization and sustained unresponsiveness.", "results_summary": "OIT demonstrated efficacy in promoting desensitization in most treated individuals, but sustained unresponsiveness after cessation was observed only in a subset. Adverse events ranged from mild symptoms to severe reactions like anaphylaxis, with multi-allergen OIT showing favorable safety and efficacy outcomes.", "population_specificity": "Individuals with food allergies, including those with single-food and multifood allergies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:55.042522+00:00"}
{"study_id": 27543, "supplement_id": 1399, "safety_score": "75", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to examine the variability in Oral Immunotherapy (OIT) protocols, including initiation approaches, buildup speed, target maintenance doses, and the use of adjuvants, to understand their implications for safety and efficacy.", "results_summary": "The study found that OIT protocols vary widely, with most starting with an initial escalation day to identify highly allergic patients, followed by a buildup period over months to years. Protocols increasingly favor low-maintenance doses, and accelerated schedules with omalizumab may be considered for severe cases.", "population_specificity": "Patients with food allergies (specific population not further detailed).", "effective_dosage": "Doses increased every 1-2 weeks by a factor of 1.25 to 2, adapted based on symptoms (exact amounts not specified).", "study_duration": "Several months to years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:55.285737+00:00"}
{"study_id": 27551, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the literature and provide practical guidance on the use of FDA-approved peanut oral immunotherapy (OIT) and shelf-bought products for treating peanut allergy.", "results_summary": "The abstract highlights that peanut OIT represents a significant advancement in food allergy treatment, enabling patients to access active treatment options. It emphasizes the impact on allergy practice but does not detail specific outcomes.", "population_specificity": "Patients with peanut allergy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:58.874857+00:00"}
{"study_id": 27550, "supplement_id": 1399, "safety_score": "70", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the emerging clinical practice guidelines for Oral Immunotherapy (OIT) in treating IgE-mediated food allergies, identifying areas of consensus and uncertainty.", "results_summary": "The study found consensus on the need for accurate diagnosis, contraindications, and proper clinical settings for OIT, but highlighted discrepancies and knowledge gaps, particularly in treating adolescents and adults. It emphasized shared decision-making due to uncertainties.", "population_specificity": "Patients with IgE-mediated food allergies (specific age groups not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:59.470204+00:00"}
{"study_id": 27552, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to describe the role of registered nurses (RNs) in the delivery of Oral Immunotherapy (OIT) within allergy/immunology interprofessional teams.", "results_summary": "The abstract highlights the multifaceted roles of RNs in OIT, including patient-centered care, clinical judgment, education, case management, and research collaboration, but does not report specific outcomes of OIT itself.", "population_specificity": "Not specified (focus is on RN roles in OIT delivery)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:00.511402+00:00"}
{"study_id": 27553, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the optimal dose, dosing frequency, and duration of Oral Immunotherapy (OIT) maintenance to achieve sustained unresponsiveness while considering the burden of care.", "results_summary": "The study suggests that higher maintenance doses, more frequent dosing, and longer duration increase the likelihood of sustained unresponsiveness but also raise the burden of care. The regimen should be individualized based on patient and family treatment goals.", "population_specificity": "Not specified", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:00.649161+00:00"}
{"study_id": 27554, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the outcomes of single-food oral immunotherapy (OIT) versus multifood OIT for patients with multiple food allergies.", "results_summary": "The study found that multifood OIT is a viable option with similar outcomes to single-food OIT, offering substantial time and cost savings. Clinics proficient in single-food OIT can transition easily to multifood OIT, and patients benefit from a more convenient treatment course.", "population_specificity": "Patients with multiple food allergies presenting for oral immunotherapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:00.829286+00:00"}
{"study_id": 27555, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness and practical application of egg oral immunotherapy for patients with persistent egg allergy, focusing on dosing protocols and addressing challenges.", "results_summary": "The study suggests that egg oral immunotherapy can enable patients to consume small amounts of egg without allergic reactions, providing protection from accidental exposures. However, it highlights the persistence of severe phenotypes in some individuals with high egg white specific IgE levels.", "population_specificity": "Patients with persistent egg allergy, particularly those with high egg white specific IgE levels and sensitization to Gal d 1.", "effective_dosage": "Gradually increasing doses of egg (specific amounts not detailed).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:03.137867+00:00"}
{"study_id": 27556, "supplement_id": 1399, "safety_score": "60", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and efficacy of Oral Immunotherapy (OIT) for food allergy, with a focus on adjunct therapies like omalizumab.", "results_summary": "OIT is the most evaluated therapeutic approach for food allergy but carries a risk of allergic reactions. Omalizumab shows promise in enhancing desensitization and reducing adverse reactions, while other biologics like dupilumab are under investigation.", "population_specificity": "Not specified (general food allergy population implied).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:03.215261+00:00"}
{"study_id": 27557, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to highlight the multidisciplinary involvement (e.g., dietitians and psychologists) required for optimal outcomes in oral immunotherapy for food allergy, focusing on patient education, nutritional health, and psychological support.", "results_summary": "The study emphasizes the critical roles of dietitians in patient education, dose preparation, and nutritional health assessment, and psychologists in addressing psychological distress and improving quality of life. It advocates for their involvement in clinical trial design and patient selection to enhance treatment outcomes.", "population_specificity": "Patients with food allergies and their caregivers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:04.548150+00:00"}
{"study_id": 27558, "supplement_id": 1399, "safety_score": "65", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to study the adverse events and quality of life impact of sesame oral immunotherapy (OIT) in a U.S. pediatric population with sesame allergy.", "results_summary": "The study found that 91.3% of patients reached maintenance therapy, with common adverse reactions including gastrointestinal (91.3%), cutaneous (78.3%), and respiratory (26%) events. Quality of life improved significantly in food-related anxiety and social/dietary limitations.", "population_specificity": "Children (8.5 \u00b1 4.7 years, 30% girls, 70% boys) with a documented history of sesame allergy.", "effective_dosage": "Not specified", "study_duration": "Buildup phase lasted 293.7 \u00b1 87.1 days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:08.695388+00:00"}
{"study_id": 27559, "supplement_id": 1399, "safety_score": "70", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the efficacy and safety of home-based wheat oral immunotherapy (OIT) using wheat noodles in children with wheat allergies.", "results_summary": "The study found that 82.0% of patients achieved desensitization to 2,400 mg of wheat protein, compared to 4.5% in the control group, though 30.0% experienced anaphylaxis during the up-dosing phase. Asthma and higher sIgE to \u03c9-5-gliadin/total IgE ratios were significant predictors of treatment outcomes.", "population_specificity": "Korean children aged 3 to 17 years diagnosed with wheat allergies.", "effective_dosage": "2,400 mg of wheat protein (via wheat noodles).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:09.451319+00:00"}
{"study_id": 27561, "supplement_id": 1399, "safety_score": "75", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to assess long-term adherence rates to the milk OIT protocol and evaluate the associated risk of allergic reactions.", "results_summary": "Only 56% of patients adhered to the maintenance protocol (200 mL of milk at least 3 times per week). Adherent patients had significantly reduced risks of allergic reactions, anaphylaxis, healthcare visits, and medication use.", "population_specificity": "50 patients who completed milk OIT and reached a maintenance dose.", "effective_dosage": "200 mL of milk at least 3 times per week.", "study_duration": "Biannual surveys (duration not explicitly stated).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:09.664636+00:00"}
{"study_id": 27566, "supplement_id": 1399, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to explore the safety and efficacy of Oral Immunotherapy (OIT) using heat-treated Lyophilized Peanut Protein-MH (LPP-MH) in peanut-allergic children.", "results_summary": "After 40 weeks of OIT, 32/33 children could consume over 300 mg of natural peanut protein, with no severe allergic reactions. By 6-12 months, most children achieved age-appropriate dietary inclusion of peanuts.", "population_specificity": "Peanut-allergic children with a single highest tolerated dose of <100 mg peanut protein.", "effective_dosage": "300 mg daily of heat-treated LPP-MH.", "study_duration": "40 weeks of treatment, with follow-up at 6-12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:12.256751+00:00"}
{"study_id": 27560, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify metabolomic pathways associated with tolerance in food allergy and responses to oral immunotherapy (OIT), particularly comparing sustained unresponsiveness (SU) versus transient desensitization (TD).", "results_summary": "The study found distinct metabolomic profiles in food allergy patients, with altered histidines and bile acids. Participants achieving SU had higher levels of immunomodulatory metabolites like lithocholate and urocanic acid, suggesting potential mechanisms of tolerance in OIT.", "population_specificity": "Multi-ethnic cohorts including healthy infants (N=384), children with asthma (N=1040), and participants in a peanut OIT trial (N=20).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:12.989995+00:00"}
{"study_id": 27567, "supplement_id": 1399, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and safety of oral immunotherapy (OIT) using enteric-coated capsules for allergic rhinitis (AR) induced by house dust mites, comparing it to subcutaneous immunotherapy (SCIT).", "results_summary": "After 1 year, both OIT and SCIT showed significant therapeutic effects, with OIT being more effective in reducing AR symptom scores and improving nasal provocation test results. No adverse reactions were reported in the OIT group, while SCIT had local and systemic reactions.", "population_specificity": "49 patients with allergic rhinitis induced by house dust mites (24 in OIT group, 25 in SCIT group).", "effective_dosage": "Not specified", "study_duration": "1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:13.793581+00:00"}
{"study_id": 27568, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to assess disparities in the use of Oral Immunotherapy (OIT) for peanut allergy based on race, ethnicity, and socioeconomic status.", "results_summary": "The study found significant racial and economic disparities in OIT access, with Black patients and those with lower socioeconomic status underrepresented in the treatment group. No differences in gender or ethnicity were observed between the OIT and control groups.", "population_specificity": "Peanut-allergic patients younger than 18 years receiving care at the University of Michigan food allergy clinics.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:13.993982+00:00"}
{"study_id": 27570, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to investigate the potential effects of oral Immunotherapy on the eradication rate of H. pylori in human studies.", "results_summary": "Three out of four studies using Immunoglobulin Y suggested significant effects on H. pylori eradication, while two out of three studies using bovine antibody found it ineffective.", "population_specificity": "Human populations with H. pylori infection.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:16.298230+00:00"}
{"study_id": 27569, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize recent advances in understanding the transcriptional pathways associated with clinical outcomes of Oral Immunotherapy (OIT) for food allergy, focusing on mechanisms like desensitization and remission.", "results_summary": "The study identified T helper 2A cells as correlating with disease activity and modified by OIT, while molecular features at study entry may predict positive outcomes. Potential mechanisms like T cell anergy and Type 1 interferon pathways were highlighted, though gaps remain in understanding long-term immune signatures.", "population_specificity": "Individuals with food allergy undergoing Oral Immunotherapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:17.494704+00:00"}
{"study_id": 27571, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate patient-related barriers to Oral Immunotherapy (OIT), including anxiety, taste aversion, and the role of healthcare professionals like dietitians.", "results_summary": "Fear of reaction was the most common barrier to OIT initiation, while taste aversion was the primary obstacle to continuation, particularly in older children. Dietitians were underutilized despite their support improving dose certainty.", "population_specificity": "Families currently enrolled in food OIT programs in Canada and the United States.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:17.881490+00:00"}
{"study_id": 27572, "supplement_id": 1399, "safety_score": "70", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of the OITcontrol app in monitoring milk and egg oral immunotherapy (OIT) compared to traditional written diaries.", "results_summary": "The OITcontrol app was found to be a valuable tool for monitoring OIT, improving adherence to treatment indications and dose adjustments after adverse reactions, though home reactions were recorded more frequently by the control group using written diaries.", "population_specificity": "Children with milk or egg allergies undergoing OIT.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:20.153076+00:00"}
{"study_id": 27573, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the efficacy of slightly processed allergen/meat from fish and crustacea in oral immunotherapy (OIT) for seafood allergy, both in mouse models and clinical patients.", "results_summary": "The meta-analysis found that crustacean allergen significantly reduced anaphylactic scores in mouse models, while slightly processed meat increased oral tolerance incidence in clinical patients. Subgroup analyses highlighted the effectiveness of specific processing methods like the Maillard reaction and simple cooking.", "population_specificity": "Mouse models and clinical patients with seafood allergy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:21.149343+00:00"}
{"study_id": 27575, "supplement_id": 1399, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "To determine the safety and effectiveness of peanut oral immunotherapy (OIT) with a slow up-dosing strategy and low maintenance dose in children aged 1 to 3 years with peanut allergy.", "results_summary": "After 1 year, 72% of children in the OIT group tolerated a cumulative dose of 750 mg peanut protein compared to 4% in the avoidance group. Adverse events were mild in 79% of cases, with only three doses of epinephrine administered to two individuals.", "population_specificity": "Children aged 1 to 3 years with peanut allergy.", "effective_dosage": "Initial low and increasing doses of peanut protein, with a median tolerated cumulative dose of 2,750 mg in the OIT group.", "study_duration": "1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:23.869840+00:00"}
{"study_id": 27574, "supplement_id": 1399, "safety_score": "70", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to review key oral immunotherapy (OIT) protocols and post-desensitization strategies for major food allergens, evaluating management choices and shared decision-making for food-allergic patients.", "results_summary": "The study found that OIT is emerging as a viable treatment option, with randomized controlled trials supporting its use for peanut, egg, milk, and wheat, and clinical reports for tree nuts and sesame. Protocols vary in dosing and maintenance strategies, with regular allergen exposure needed to maintain desensitization.", "population_specificity": "Food-allergic patients, including those allergic to peanut, egg, milk, wheat, tree nuts, and sesame.", "effective_dosage": "Not specified (varies by protocol)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:24.298309+00:00"}
{"study_id": 27578, "supplement_id": 1399, "safety_score": "65", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to systematically analyze the efficacy and safety of oral immunotherapy (OIT) combined with biological agents for treating food allergy.", "results_summary": "The abstract indicates that OIT has shown effectiveness in desensitization but frequently causes adverse events, including anaphylaxis, and some patients fail to achieve sustained desensitization. Biological agents like omalizumab may serve as adjunctive therapy to improve OIT outcomes.", "population_specificity": "Patients with severe food allergy (specific population not further detailed in the abstract).", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:26.191413+00:00"}
{"study_id": 27576, "supplement_id": 1399, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety of multifood sublingual immunotherapy (SLIT) in pediatric patients and assess its effectiveness in bypassing the buildup phase of oral immunotherapy (OIT).", "results_summary": "The study found SLIT to be very safe, with no life-threatening reactions and only 2.10% of patients requiring epinephrine. A subset of patients successfully bypassed OIT buildup after 1-2 years of SLIT, with 70% passing a low-dose oral food challenge.", "population_specificity": "Pediatric patients aged 4 to 18 years with food allergies.", "effective_dosage": "2 mg protein SLIT maintenance dose, built up over 3-5 visits.", "study_duration": "1 to 2 years of daily SLIT maintenance.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:26.472020+00:00"}
{"study_id": 27577, "supplement_id": 1399, "safety_score": "85", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether a low-dose oral food challenge could safely bypass the build-up phase of oral immunotherapy for shrimp-allergic children.", "results_summary": "Of 17 children who completed the low-dose oral food challenge, 53% tolerated 300 mg shrimp protein with no reaction, while 47% had mild reactions. 94% continued daily maintenance immunotherapy without anaphylaxis.", "population_specificity": "Children aged 3-17 years with shrimp allergy confirmed by skin prick test, specific IgE levels, or objective IgE-mediated reactions.", "effective_dosage": "300 mg shrimp protein daily", "study_duration": "January 2020 to April 2023 (approximately 3 years)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:26.687241+00:00"}
{"study_id": 27579, "supplement_id": 1399, "safety_score": "80", "efficacy_score": 90, "quality_score": 95, "study_goal": "The researchers aimed to determine the safety and efficacy of peanut allergen powder-dnfp (PTAH) oral immunotherapy in desensitizing peanut-allergic children aged 1 to <4 years.", "results_summary": "PTAH-treated participants showed a 73.5% desensitization rate (tolerating \u2265600 mg peanut protein) compared to 6.3% in the placebo group. Most adverse events were mild to moderate, with no severe or serious treatment-related systemic allergic reactions reported.", "population_specificity": "Peanut-allergic children aged 1 to <4 years.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Approximately 12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:29.418987+00:00"}
{"study_id": 27564, "supplement_id": 1399, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety, efficacy, and factors influencing the success of Oral Immunotherapy (OIT) for IgE-mediated food allergies, including age, dose, frequency, and duration.", "results_summary": "OIT was found to be effective and safe in infants, increasing tolerance thresholds for common food allergens. Early initiation improved desensitization rates, even for foods with a natural tendency for allergy resolution. Ongoing studies are exploring protocol modifications and clinical monitoring tools to enhance OIT success.", "population_specificity": "Infants with IgE-mediated food allergies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:30.195443+00:00"}
{"study_id": 27581, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the relationship between peanut-specific IgE and IgG4 levels and clinical outcomes in participants receiving peanut oral immunotherapy (PTAH) versus placebo.", "results_summary": "The study found no correlation between baseline IgE/IgG4 levels and clinical response to PTAH, but noted significant immunological changes (e.g., postscreening IgE/IgG4 ratio shifts) in the PTAH group compared to placebo. PTAH contained immunodominant allergens, inducing measurable immune changes.", "population_specificity": "269 participants (202 PTAH, 67 placebo) from the PALISADE trial.", "effective_dosage": "Not specified in abstract.", "study_duration": "Not specified in abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:30.398592+00:00"}
{"study_id": 27582, "supplement_id": 1399, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the benefits and risks of food oral immunotherapy (food-OIT) as an active treatment for food allergy, focusing on its impact on reactivity thresholds, reaction severity, dietary choices, anxiety, and quality of life.", "results_summary": "The study found that food-OIT increases the threshold of reactivity to allergenic foods, reduces reaction severity upon accidental exposure, expands dietary options, lowers anxiety, and improves quality of life, though it carries risks of allergic reactions during therapy.", "population_specificity": "Patients with food allergies and their families in westernised countries.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:33.260898+00:00"}
{"study_id": 27583, "supplement_id": 1399, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "To evaluate the clinical outcome and immune marker changes of a lightened version of egg oral immunotherapy (OIT) in children with egg allergy.", "results_summary": "All 18 patients in the OIT group were successfully desensitized within an average of 4.5 months, with significant immune marker changes (reduced IgE, increased IgA1, IgA2, and IgG4). Only 2 of 17 control group children tolerated egg after 1 year.", "population_specificity": "Egg-allergic children (18 in OIT group, 17 in control group).", "effective_dosage": "Egg powder with short up-dosing, maintained by egg in daily diet (specific amounts not detailed).", "study_duration": "1 year (including up-dosing and maintenance phases).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:34.270869+00:00"}
{"study_id": 27584, "supplement_id": 1399, "safety_score": "65", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to identify factors associated with difficulties in wheat oral immunotherapy (OIT) for children with IgE-mediated wheat allergy.", "results_summary": "Higher initial wheat and omega-5-gliadin-specific IgE levels were significant risk factors for complications during OIT, including frequent adverse reactions or protocol deviations. Anaphylaxis during oral food challenge tests also increased complication risks.", "population_specificity": "Children under 18 years with a history of IgE-mediated wheat allergy.", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 2 years (IQR 1.2-3.0 years)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:34.459933+00:00"}
{"study_id": 27586, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess shifts in IgE and IgG4 binding to peanut allergens and their epitopes in US peanut-allergic participants undergoing oral immunotherapy (OIT) with peanut allergen powder-dnfp (PTAH).", "results_summary": "The study found statistically significant decreases in IgE binding to intact Ara h 2, 3, and 6, with shifts towards IgG4 binding post-OIT. Increased IgG4 binding was more critical for desensitization at 12 months than decreased IgE.", "population_specificity": "US peanut-allergic participants (n=20) enrolled in phase 3 PTAH OIT clinical trials.", "effective_dosage": "Not specified", "study_duration": "Approximately 12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:36.457115+00:00"}
{"study_id": 27585, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to identify baseline clinical and demographic factors that modify the effects of probiotic peanut oral immunotherapy (PPOIT) and peanut oral immunotherapy (OIT) on remission and health-related quality of life (HRQL).", "results_summary": "Both PPOIT and OIT were effective in inducing clinical remission and improving HRQL, but higher peanut sensitivity and concurrent allergic conditions reduced remission likelihood. Anaphylaxis history reduced remission likelihood more with PPOIT than OIT, while sex, anaphylaxis history, and age modified HRQL outcomes.", "population_specificity": "201 children aged 1-10 years with challenge-confirmed peanut allergy.", "effective_dosage": "Cumulative 4,950-mg peanut protein at 8 weeks after treatment (specific dosing frequency not detailed).", "study_duration": "18 months of treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:37.126989+00:00"}
{"study_id": 27588, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of early oral immunotherapy (e-OIT) in achieving sustained unresponsiveness (SU) in young children with food allergies and explore the underlying immune mechanisms.", "results_summary": "The study found that e-OIT in children under 4 years showed a more favorable outcome in achieving SU compared to older patients, suggesting an early-life window of opportunity for intervention. However, the underlying mechanism for this higher effectiveness remains unclear.", "population_specificity": "Children younger than 4 years of age with food allergies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:38.625594+00:00"}
{"study_id": 27589, "supplement_id": 1399, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to compare patients who completed Oral Immunotherapy (OIT) with and without Omalizumab (OMZ), identify predictors for OMZ need, and evaluate long-term OMZ use and withdrawal safety.", "results_summary": "93% of patients achieved desensitization; OMZ reduced allergic reaction rates (p < 0.001) and most patients (81%) discontinued OMZ successfully without severe reactions. Lower reaction doses during oral challenge predicted OMZ need (p = 0.037).", "population_specificity": "Patients with IgE-mediated food allergy, some requiring OMZ due to severe/frequent allergic reactions (10-20%).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:39.702813+00:00"}
{"study_id": 27587, "supplement_id": 1399, "safety_score": "70", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the cost-effectiveness of probiotic-adjuvanted peanut oral immunotherapy (PPOIT) versus placebo in children with peanut allergy, focusing on sustained unresponsiveness and quality-adjusted life years.", "results_summary": "PPOIT showed significantly higher effectiveness than placebo, with a 54% sustained unresponsiveness rate versus 6%, and improved QALYs (9.05 vs. 8.63). Despite higher healthcare costs, PPOIT was deemed cost-effective at approximately $A20,000 per QALY gained.", "population_specificity": "56 children aged 1-10 years with peanut allergy.", "effective_dosage": "Daily dose of probiotic Lactobacillus rhamnosus CGMCC 1.3724 (NCC4007) and peanut oral immunotherapy.", "study_duration": "1.5 years of treatment, with 10 years total follow-up (including post-treatment and extrapolation).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:40.038822+00:00"}
{"study_id": 27590, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the efficacy and safety of peanut oral immunotherapy (OIT) compared to standard care (avoidance) in inducing desensitization in children aged 1-4 years with peanut allergy.", "results_summary": "The study is designed to assess the proportion of children achieving a peanut eliciting dose >600 mg peanut protein after 12 months of OIT, with secondary outcomes including safety, quality of life, and immunological changes. Results are pending as the trial is ongoing.", "population_specificity": "Children aged 1-4 years with peanut allergy.", "effective_dosage": "Daily peanut OIT (specific dose not detailed in abstract).", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:42.549018+00:00"}
{"study_id": 27592, "supplement_id": 1399, "safety_score": "60", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the limitations of current oral immunotherapy (OIT) for peanut allergies and explore alternative routes to improve safety and efficacy.", "results_summary": "The study found that while OIT reduces allergic reactions, its strict regimen and risk of severe adverse events limit its appeal. Alternative immunotherapy routes (sublingual, epicutaneous, intranasal) may offer safer and more effective desensitization with lower allergen doses.", "population_specificity": "Preclinical animal models and clinical studies addressing food allergies (primarily peanut allergies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:42.864304+00:00"}
{"study_id": 27591, "supplement_id": 1399, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and effectiveness of low-dose sesame oral immunotherapy (200 mg protein) in preschoolers with sesame allergy.", "results_summary": "The study found that low-dose S-OIT was safe, with 32.1% of subjects experiencing no reactions during buildup and 85.7% successfully completing the exit oral food challenge. Most adverse reactions were mild (grade 1 or 2), and only one subject required epinephrine.", "population_specificity": "Preschoolers (median age 33.5 months) with sesame allergy, confirmed by history of objective reactions and positive skin prick tests or IgE levels.", "effective_dosage": "200 mg sesame protein daily as maintenance dose.", "study_duration": "1 year of maintenance dosing.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:44.174833+00:00"}
{"study_id": 27593, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the immune signatures and baseline conditions related to oral immunotherapy for peanut allergy, focusing on its potential to induce sustained unresponsiveness.", "results_summary": "The study highlights that oral immunotherapy can reshape the immune system toward higher threshold dose reactivity, with young patients, especially those under 3 years old, showing the best chance for success. However, surrogate markers for therapy duration and response remain unclear, and further research is needed to fill knowledge gaps.", "population_specificity": "Peanut-allergic patients, particularly young children under 3 years old.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:45.054808+00:00"}
{"study_id": 27594, "supplement_id": 1399, "safety_score": "85", "efficacy_score": 90, "quality_score": 95, "study_goal": "The researchers aimed to evaluate the long-term safety and changes in peanut sensitization markers in individuals undergoing peanut oral immunotherapy (PTAH) over approximately 5 years.", "results_summary": "The study found a trend of decreasing adverse events over time, with most being mild or moderate, and improved immunologic markers (reduced peanut-specific IgE, increased IgG4, and lowered IgE:IgG4 ratio). A reduction in peanut skin prick test wheal diameter was also observed.", "population_specificity": "Individuals aged 4 to 17 years with peanut allergy.", "effective_dosage": "Initial dose escalation (6 mg over 2 days), updosing (increased every 2 weeks to 300 mg for \u22656 months), and maintenance (300 mg daily).", "study_duration": "Approximately 5 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:47.020327+00:00"}
{"study_id": 27595, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of PPI treatment in children with EoE induced by OIT versus EoE from other causes and describe the clinical and histological features of EoE+OIT.", "results_summary": "PPI treatment was similarly effective in both EoE+OIT and EoE-OIT groups, with high clinical and endoscopic response rates and better histological response in the EoE+OIT group.", "population_specificity": "42 children (74% male, mean age 11.2) with EoE, including 11 with EoE induced by OIT.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:47.670139+00:00"}
{"study_id": 27597, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to modify and validate the OIT-PB questionnaire to assess parental burden related to oral immunotherapy for food allergies.", "results_summary": "The modified OIT-PB questionnaire demonstrated high reliability and validity, identifying four subscales of parental burden. Significant correlations were found between OIT-PB and other validated scales (FAQLQ-PB and SRS-18), and a negative correlation was observed between treatment effect anxiety and food intake rate.", "population_specificity": "Parents of children with food allergies undergoing oral immunotherapy for the first time.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:48.531857+00:00"}
{"study_id": 27596, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the association between the duration of Oral Immunotherapy (OIT) treatment and the achievement of sustained unresponsiveness (SU) in children with peanut allergies.", "results_summary": "The study found that 71% of patients achieved SU, with the rate increasing over the therapeutic period, peaking at 2.7 person-years. The median period until SU achievement was 2.1 person-years.", "population_specificity": "Children with persistent peanut allergies, median starting age of 8 years, 85% with a history of anaphylaxis.", "effective_dosage": "Peanut dose gradually increased to 3,000 mg (795 mg peanut protein) during oral food challenge, maintained for \u22655 months.", "study_duration": "Median observational period was 2.1 person-years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:50.126902+00:00"}
{"study_id": 27598, "supplement_id": 1399, "safety_score": "40", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to examine the ethical and clinical implications of continuing oral immunotherapy (OIT) in patients diagnosed with eosinophilic esophagitis (EoE), despite its traditional contraindication.", "results_summary": "The study found that while OIT may induce EoE, most patients experience symptom resolution and histologic remission after discontinuing OIT. However, recent studies report OIT continuation even after EoE onset, creating ethical and clinical challenges.", "population_specificity": "Patients with eosinophilic esophagitis (EoE) undergoing oral immunotherapy (OIT).", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:51.290299+00:00"}
{"study_id": 27599, "supplement_id": 1399, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to establish the long-term safety and efficacy of a novel red meat oral immunotherapy (OIT) for adults with galactose-alpha-1,3-galactose (alpha-gal) allergy.", "results_summary": "All patients who underwent OIT became tolerant to red meat, with a gradual decrease in alpha-gal sIgE concentrations over 5 years. Rare tick bites induced hypersensitivity reactions in two patients, but one patient with low sIgE levels consumed red meat uneventfully despite frequent tick bites.", "population_specificity": "Adults with confirmed red meat allergy due to alpha-gal sensitivity.", "effective_dosage": "Desensitized patients were recommended to eat at least 100 g of red meat daily for 6 months, then every other day for the next 6 months, followed by 2-3 times per week after a year.", "study_duration": "5-year follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:53.275309+00:00"}
{"study_id": 27601, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore whether abatacept, as an adjuvant to peanut OIT, could promote immune tolerance in peanut-allergic individuals aged 14-55 years.", "results_summary": "The study is ongoing, but the primary outcome focuses on suppressing the OIT-induced surge in peanut-specific IgE/total IgE at 24 weeks, with sustained unresponsiveness assessed later. Preclinical data suggest potential efficacy, but human results are pending.", "population_specificity": "Peanut-allergic participants aged 14-55 years.", "effective_dosage": "Target maintenance dose of 300 mg peanut protein.", "study_duration": "24 weeks for primary outcome, with follow-up assessments starting at 36 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:53.723953+00:00"}
{"study_id": 27602, "supplement_id": 1399, "safety_score": "75", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the safety, efficacy, and practical considerations of Oral Immunotherapy (OIT) for children with hen's egg (HE) or cow's milk (CM) allergies.", "results_summary": "OIT was found to reduce parental burden related to allergen avoidance and induce desensitization and immune tolerance, though it requires careful monitoring by specialists. Contraindications include uncontrolled asthma, malignancy, and certain autoimmune disorders, but a history of anaphylaxis or multiple food allergies does not preclude OIT.", "population_specificity": "Children with long-lasting allergies to hen's eggs or cow's milk.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Contraindicated with beta-blockers.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:54.159633+00:00"}
{"study_id": 27603, "supplement_id": 1399, "safety_score": "65", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the current practices and barriers related to Oral Immunotherapy (OIT) among allergists in the United States, comparing academic and nonacademic settings.", "results_summary": "The survey revealed that 50% of responders offered OIT in their practice, with similar practices across academic and nonacademic settings regarding the number of foods offered, oral food challenges, and patient demographics. Key barriers included staff and time limitations, safety concerns, and inadequate compensation, with clinic space limitations being more prominent in academic settings.", "population_specificity": "Allergists practicing in the United States.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:55.966748+00:00"}
{"study_id": 27604, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review existing data on clinical and immunological outcomes of peanut oral immunotherapy (pOIT) to inform best practices for selecting patients most likely to benefit from it.", "results_summary": "The study summarizes immunological and clinical outcomes of pOIT across different ages, suggests an ideal age range for initiating pOIT, and highlights the need for further research on optimal timing and patient selection.", "population_specificity": "Patients with peanut allergy, with consideration of different age groups.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:56.311219+00:00"}
{"study_id": 27605, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to develop a systematic method to estimate the protein content of common allergens in retail foods and create patient education materials for safe dietary introduction after oral immunotherapy.", "results_summary": "The study identified retail food equivalents for seven allergens at six serving sizes and developed 48 patient education materials, providing guidance on estimating allergen protein content systematically.", "population_specificity": "Patients with food allergy, particularly those undergoing oral immunotherapy or needing dietary introduction of allergens.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:57.245697+00:00"}
{"study_id": 27607, "supplement_id": 1399, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety, efficacy, and factors influencing the success of Oral Immunotherapy (OIT) in increasing tolerance thresholds for IgE-mediated food allergies.", "results_summary": "OIT was found to be effective and safe in infants, with early initiation improving desensitization rates even for foods where natural allergy loss is common. Ongoing studies are exploring protocol modifications and clinical tools to enhance OIT success and monitoring.", "population_specificity": "Infants with IgE-mediated food allergies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:59.080966+00:00"}
{"study_id": 27608, "supplement_id": 1399, "safety_score": "40", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the limitations of Oral Immunotherapy (OIT) for food allergies and explore potential strategies to enhance its safety and efficacy.", "results_summary": "OIT is effective at inducing desensitization to food allergens but has limitations such as a long build-up duration, high rate of adverse events, and variable effectiveness across patients. Emerging strategies, including biologics and novel therapies, show promise in improving OIT outcomes.", "population_specificity": "Not specified (general food allergy population implied).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:59.680852+00:00"}
{"study_id": 27612, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the ethical considerations and implementation of Oral Immunotherapy (OIT) in children, focusing on principles like autonomy, beneficence, nonmaleficence, and justice.", "results_summary": "The study found that ethical principles are crucial in guiding OIT decisions, with shared decision-making being central to individualized care. While OIT can promote health and well-being, challenges like equity and access must be addressed.", "population_specificity": "Children with food allergies, particularly young children whose families act as surrogate decision-makers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:02.482832+00:00"}
{"study_id": 27610, "supplement_id": 1399, "safety_score": "80", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine if E-B-FAHF-2 improved remission rates in subjects undergoing omalizumab-facilitated multiallergen OIT.", "results_summary": "Omalizumab-facilitated multi-OIT was safe and effective, with 24.2% achieving remission, but E-B-FAHF-2 did not improve outcomes compared to placebo.", "population_specificity": "Subjects undergoing multiallergen OIT (n=33).", "effective_dosage": "Maintenance dose of 1000 mg of each allergen.", "study_duration": "24 months of multi-OIT, plus 2 months pre-OIT and 2-month build-up phase.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:02.680287+00:00"}
{"study_id": 27611, "supplement_id": 1399, "safety_score": "65", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the latest evidence on oral immunotherapy (OIT) for food allergy, focusing on its efficacy, safety, immune mechanisms, and ongoing research to improve therapeutic outcomes.", "results_summary": "The study found that OIT shows promise in raising reaction thresholds and accelerating tolerance for allergens like peanuts, eggs, and milk, but safety concerns and long-term effects remain unresolved. Growing evidence supports its efficacy, though gaps in current knowledge highlight the need for further research.", "population_specificity": "Individuals with food allergies, particularly to peanuts, eggs, and milk.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:03.163716+00:00"}
{"study_id": 27613, "supplement_id": 1399, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy of oral immunotherapy with peanut allergen powder-dnfp (PTAH) in reducing allergic symptoms and improving tolerance to peanut exposure in children and adolescents with peanut allergy.", "results_summary": "PTAH significantly reduced symptom severity and increased the proportion of participants who remained asymptomatic during peanut exposure, with notable improvements in respiratory, gastrointestinal, cardiovascular/neurological, and dermatological symptoms. The treatment also showed continued benefit with longer maintenance periods.", "population_specificity": "Children and adolescents aged 4 to 17 years with peanut allergy.", "effective_dosage": "Maximum peanut protein doses of 1000 mg (PALISADE, ARTEMIS) and 2000 mg (ARC004) during DBPCFCs.", "study_duration": "Maintenance treatment durations ranged from ~6 months to ~20 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:06.467676+00:00"}
{"study_id": 27615, "supplement_id": 1399, "safety_score": "70", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy, safety, and real-world impact of Oral Immunotherapy (OIT) for IgE-mediated food allergies, focusing on desensitization, patient experience, and protocol optimization.", "results_summary": "Studies confirmed OIT's efficacy in desensitizing children allergic to cow's milk, eggs, and peanuts, though patient selection criteria remain non-consensual. The abstract highlights ongoing challenges, including defining long-term efficacy and optimizing protocols, while noting recent regulatory progress in peanut OIT.", "population_specificity": "Children with IgE-mediated food allergies (specifically cow's milk, eggs, and peanuts).", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:06.929752+00:00"}
{"study_id": 27614, "supplement_id": 1399, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and safety of a combined SLIT-peach and OIT protocol using commercial peach juice in patients with LTP syndrome.", "results_summary": "The combination therapy was well tolerated (80.5% for SLIT, 85% for OIT) with no severe adverse reactions, and 86.6% of patients successfully passed the final provocation. One month later, 93.3% had no dietary restrictions, and quality of life significantly improved.", "population_specificity": "Patients with LTP syndrome who are not sensitized to storage proteins, mostly with LTP anaphylaxis.", "effective_dosage": "SLIT-peach ALK followed by OIT with Granini\u00ae peach juice, progressively increased to 200 ml over 42 days.", "study_duration": "Approximately 82 days (40 days SLIT maintenance + 42 days OIT).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:07.008085+00:00"}
{"study_id": 28988, "supplement_id": 1400, "safety_score": "90", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate whether protein type or hydrolysation affects absorption from iso-osmolar oral rehydration solutions (ORS) in patients with an ileostomy.", "results_summary": "The study found no change in ileostomy output across the three protein-based ORS interventions, but whey protein isolate ORS showed discrete improvements in absorption proxies, including reduced fecal energy loss and improved plasma markers. The ORS were safe and well-tolerated.", "population_specificity": "Patients with an ileostomy (14 enrolled, 13 completed at least one intervention, 10 completed all three).", "effective_dosage": "500 mL/day of ORS containing 40-48 g protein/L and 34-45 mmol sodium/L.", "study_duration": "Three 4-week intervention periods with >2-week washout between each.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:09.322451+00:00"}
{"study_id": 28989, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the optimal composition of oral rehydration solutions (ORS) for diarrheic calves by evaluating water, mineral, and blood acid-base balance.", "results_summary": "The study found that hypotonic ORS with low sodium (HYPO) significantly improved blood acid-base balance compared to placebo, while hypertonic ORS (HYPER) resulted in greater fecal sodium losses without significant benefits. HYPO was more effective in sustaining hydration and electrolyte balance in diarrheic calves.", "population_specificity": "45 diarrheic calves (age: 18 \u00b1 3.2 days).", "effective_dosage": "2.0 L of ORS (HYPER or HYPO) or placebo (CON) administered twice daily between milk meals.", "study_duration": "5 days (intervention administered from day 1 to day 3).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:09.842948+00:00"}
{"study_id": 28990, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to explore why glucose-based oral rehydration solutions (ORS) are widely recommended but poorly adopted, and to propose a novel hypothesis regarding their effects on diarrhea.", "results_summary": "The study found that glucose in ORS can stimulate both intestinal absorption and secretion, potentially exacerbating diarrhea in cases where pathogens affect glucose transport. It suggests that modern ORS formulations should focus on reducing stool volume and diarrhea duration while replacing water and electrolytes.", "population_specificity": "Not specified (general discussion of physiological mechanisms)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:10.431203+00:00"}
{"study_id": 28991, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effect of ORS tonicity (hypotonic, isotonic, hypertonic) on water, mineral, and acid-base balance in dehydrated calves.", "results_summary": "Low tonicity ORS were more effective at restoring water, mineral, and acid-base balance than hypertonic ORS. Hypertonic ORS led to lower blood pH and greater fecal Na+ losses compared to hypotonic and isotonic ORS.", "population_specificity": "Seventy-two calves with varying dehydration severity and blood base excess.", "effective_dosage": "2.0 L of ORS administered twice daily (1300 and 2100 hr).", "study_duration": "3 days of intervention, with monitoring for 5 days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:11.584897+00:00"}
{"study_id": 28993, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to assess compliance of pre-mixed and powdered ORS products with WHO osmolality guidelines and examine their osmotic shelf-life stability.", "results_summary": "Only one pre-mixed ORS product complied with WHO guidelines before and after storage, while five of six powdered ORS products complied with minimal variation. Osmotic stability was questionable for some products due to ingredient composition.", "population_specificity": "Not specified (commercially available ORS products).", "effective_dosage": "Not specified.", "study_duration": "Two months (for shelf-life stability testing).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:11.654168+00:00"}
{"study_id": 28995, "supplement_id": 1400, "safety_score": "80", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to assess the taste and compliance of two different oral rehydration solutions (ORS) among patients with short bowel syndrome (SBS) requiring home parenteral nutrition (HPN).", "results_summary": "Taste ratings were similar for both ORS types (7.3 vs. 7.6 on a 1-10 scale), but a significant number of participants dropped out due to poor taste or intolerance. Compliance was moderately high, with participants consuming ORS 6.0-6.6 days per week on average.", "population_specificity": "Patients with short bowel syndrome (SBS) requiring home parenteral nutrition (HPN) with anticipated duration >3 months.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:16.027418+00:00"}
{"study_id": 28996, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to assess knowledge and perceptions about ORS use for diarrheal disease management among health providers and caregivers in Santa Rosa, Guatemala, and recommend strategies to increase ORS adoption.", "results_summary": "The study found cultural beliefs influenced diarrhea treatment, with caregivers favoring bottled ORS and antidiarrheals over ORS packets. Knowledge gaps existed regarding dehydration management and ORS use.", "population_specificity": "Formal and informal healthcare providers and community caregivers in Santa Rosa, Guatemala.", "effective_dosage": "Not specified", "study_duration": "Data collected from July to September 2008 (exact intervention duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:16.505653+00:00"}
{"study_id": 28997, "supplement_id": 1400, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the utility of oral rehydration solution therapy (ORST) as an alternative to intravenous fluid therapy for burn injury treatment, particularly in resource-limited settings.", "results_summary": "The study found that ORST is beneficial in the acute phase of burn injuries, especially when intravenous rehydration is unavailable, due to its availability, ease of administration, low risk of complications, and cost-effectiveness. Further research is suggested to optimize ORST for broader burn injury applications.", "population_specificity": "Burn patients in resource-limited settings (e.g., battlefield, underdeveloped nations, mass casualties).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:16.846221+00:00"}
{"study_id": 28998, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to understand caregiver and healthcare provider perceptions of ORS, reasons for its low use, and opportunities to expand its adoption in India and Kenya.", "results_summary": "Caregivers generally had positive perceptions of ORS but often prioritized antibiotics for diarrhea treatment. Misconceptions about ORS's purpose (e.g., expecting it to stop diarrhea) were common, and inappropriate treatments, including antibiotic overuse, were prevalent.", "population_specificity": "Caregivers and healthcare providers in India and Kenya, focusing on children under five with diarrheal disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:18.030056+00:00"}
{"study_id": 29000, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the palatability of different flavored oral rehydration solutions (ORS) among children and determine their flavor preferences and associations with their taste preferences.", "results_summary": "Cola-flavored ORS was most preferred (87.9% rated it good or really good), followed by strawberry (62.1%). Children who liked cola drinks strongly preferred cola-flavored ORS, while no such association was found for strawberry. Neutral solutions were preferred by children who disliked both cola and strawberry.", "population_specificity": "116 pediatric patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:18.479653+00:00"}
{"study_id": 28999, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the palatability of three oral rehydration solutions (Pedialyte, Pediatric Electrolyte, and Enfalyte) in children.", "results_summary": "Pedialyte and Pediatric Electrolyte were significantly more palatable than Enfalyte, with higher taste scores and greater willingness to consume again. Volume consumed did not differ significantly between solutions.", "population_specificity": "66 children aged 5 to 10 years with non-gastrointestinal concerns.", "effective_dosage": "Ad libitum consumption during a 15-minute period.", "study_duration": "15 minutes per solution (3-period crossover).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:18.957230+00:00"}
{"study_id": 29001, "supplement_id": 1400, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to review the effectiveness and modifications of Oral Rehydration Solutions (ORS), including the standard WHO-ORS and newer variations, in managing acute diarrhea and related conditions.", "results_summary": "The study found that WHO-ORS significantly reduces mortality in children with acute diarrhea by improving hydration, though it does not reduce stool volume or diarrhea duration. Various modifications, such as hypo-osmolar solutions and rice-based ORS, showed mixed success, with some still under investigation.", "population_specificity": "Children and adults with acute diarrhea, travelers' diarrhea, and patients with short bowel syndrome requiring parenteral nutrition.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:19.990793+00:00"}
{"study_id": 29002, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of oral rehydration solutions (ORS) on milk clotting, abomasal pH, electrolyte concentrations, and acid-base status in suckling calves, as well as their potential to treat metabolic acidosis in diarrheic calves.", "results_summary": "ORS did not interfere with milk clotting in the abomasum and could be administered with milk. MR-ORS mixtures with high [SID(3)] values increased serum [SID(3)] and may effectively treat metabolic acidosis in calves with diarrhea.", "population_specificity": "Suckling calves with abomasal cannulas", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:20.559934+00:00"}
{"study_id": 29005, "supplement_id": 1400, "safety_score": "90", "efficacy_score": 95, "quality_score": 85, "study_goal": "The researchers aimed to highlight the importance, efficacy, and underutilization of Oral Rehydration Solutions (ORS) in preventing and treating acute dehydration caused by gastroenteritis in infants.", "results_summary": "ORS has been proven effective for over 50 years in preventing and treating acute dehydration, significantly reducing child mortality due to diarrhea. Despite its efficacy, ORS remains underprescribed and underused, contributing to preventable dehydration and deaths.", "population_specificity": "Infants, particularly those with acute diarrhea or gastroenteritis.", "effective_dosage": "Ad libitum (as needed) during diarrhea episodes.", "study_duration": "Not specified (ongoing during diarrhea).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:25.823753+00:00"}
{"study_id": 29003, "supplement_id": 1400, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to assess the safety of rapid intravenous rehydration in severely malnourished children and compare the efficacy of three oral rehydration solutions (glucose-ORS, glucose-ORS with amylase-resistant starch, and rice-ORS).", "results_summary": "Intravenous rehydration was safe and effective, with no cases of overhydration or heart failure. Rice-ORS significantly reduced stool output and ORS intake compared to glucose-ORS, though all solutions were equally effective in correcting dehydration.", "population_specificity": "Severely malnourished children (weight/length <70% of median) aged 6-36 months with cholera.", "effective_dosage": "100 mL/kg of intravenous solution for severely dehydrated children before randomization; ORS formulations had identical electrolytes.", "study_duration": "Acute and convalescence phases; mean duration of diarrhea was 66 hours.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:25.949852+00:00"}
{"study_id": 29008, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine if soluble zinc chelates in oral rehydration solutions could modulate the effects of nitric oxide (NO) excess on small intestinal absorption and secretion.", "results_summary": "Zinc-citrate and zinc-histidine effectively removed chemically generated NO in vitro. In vivo, zinc-citrate partially reversed NO-induced potassium malabsorption but did not affect sodium or water absorption.", "population_specificity": "Healthy rats under anesthesia.", "effective_dosage": "1 mM zinc-citrate in oral rehydration solution.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:26.736919+00:00"}
{"study_id": 29007, "supplement_id": 1400, "safety_score": "90", "efficacy_score": 95, "quality_score": 85, "study_goal": "The researchers aimed to review the development, efficacy, and formulation of Oral Rehydration Solutions (ORS) in preventing and treating dehydration caused by acute gastroenteritis.", "results_summary": "The study found that ORS solutions are highly effective in managing acute gastroenteritis, with enhanced efficacy due to reduced osmolarity in newer formulations. The widespread use of ORS has significantly improved outcomes in both children and adults.", "population_specificity": "Children and adults with acute gastroenteritis or short gut syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:26.786551+00:00"}
{"study_id": 29006, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the effectiveness and feasibility of adding zinc to oral rehydration solutions (ORS) for controlling diarrhea in adult patients with intestinal failure caused by short bowel syndrome.", "results_summary": "The abstract does not provide specific results but suggests that recommendations for ORS composition in adults are based on studies of oral zinc supplementation for acute diarrhea in children. The effectiveness of zinc-enriched ORS for adults with short bowel syndrome remains unstudied.", "population_specificity": "Adult patients with intestinal failure caused by short bowel syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:27.202428+00:00"}
{"study_id": 29004, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of adding oral rehydration therapy (ORT) solutions containing bicarbonate, citrate, and acetate to cow's milk on milk clotting, abomasal pH, and abomasal emptying rate in suckling calves.", "results_summary": "The study found that adding a BACG-ORT solution to cow's milk increased in vitro clotting time by 6 minutes but did not affect in vivo clotting. The ORT solutions increased abomasal pH by 0.3 units and slowed abomasal emptying. In vitro recommendations against bicarbonate- or citrate-containing ORT solutions with cow's milk were not supported under in vivo conditions.", "population_specificity": "Six male Holstein-Friesian calves, 5 to 13 days old, with abomasal cannulae.", "effective_dosage": "2 L of cow's milk with ORT solutions (low bicarbonate: 25 mmol/L, acetate: 12 mmol/L, citrate: 12 mmol/L, glycine: 7 mmol/L; or formate: 58 mmol/L, acetate: 15 mmol/L).", "study_duration": "Single administration in a crossover design (exact duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:29.454203+00:00"}
{"study_id": 29009, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether adding zinc to an oral rehydration solution (ORS) could regulate nitric oxide metabolite synthesis in zinc-deficient rat intestines, potentially improving intestinal function and zinc status.", "results_summary": "The study found that ORS with zinc (ORS+Zn) increased plasma zinc levels, normalized nitric oxide synthase activity, reduced NF-kappaB DNA binding activity, and improved intestinal villi absorption compared to ORS without zinc. These results suggest zinc-enhanced ORS may aid recovery from diarrhea and reduce recurrence risks.", "population_specificity": "Young male rats fed a zinc-deficient diet to mimic recurrent diarrheal conditions in humans.", "effective_dosage": "1 mM zinc added to ORS.", "study_duration": "Two days of ORS administration following three weeks of zinc-deficient diet and five days of cathartic-induced diarrhea.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:31.326532+00:00"}
{"study_id": 29011, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy of low-sodium low-glucose ORS and rice-based hypo-osmolar ORS with standard WHO glucose ORS in treating severe cholera in children.", "results_summary": "The rice-based hypo-osmolar ORS significantly reduced stool output, ORS consumption, and diarrhea duration compared to WHO-ORS and glucose-based hypo-osmolar ORS. All treatments were administered alongside tetracycline.", "population_specificity": "Children aged 2-10 years with severe cholera (Vibrio cholerae-positive).", "effective_dosage": "Tetracycline at 50 mg/kg/day in 4 divided doses for 3 days (ORS dosages not specified).", "study_duration": "3 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:31.886699+00:00"}
{"study_id": 29012, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of two hypotonic oral rehydration solutions with different osmolarities and the addition of Lactobacillus GG in treating acute diarrhea in young children.", "results_summary": "Early administration of Lactobacillus GG combined with a reduced osmolarity oral rehydration solution (224 mosmol/l) resulted in the shortest duration of diarrhea, best weight gain, and fastest correction of acidosis. Further reduction of osmolarity did not show additional benefits.", "population_specificity": "Children aged 6-36 months hospitalized for acute diarrhea.", "effective_dosage": "Not specified (osmolarities: 224 mosmol/l and 204 mosmol/l; Na+ 60 mmol/l, glucose 84 mmol/l or 64 mmol/l).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:35.618284+00:00"}
{"study_id": 29015, "supplement_id": 1400, "safety_score": "90", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of a packaged ready-to-mix rice oral rehydration solution (ORS) to the standard glucose ORS in treating childhood diarrhoea.", "results_summary": "The study found no significant differences between the rice ORS and standard glucose ORS in stool output, ORS intake, duration of diarrhoea, or weight gain during follow-up. Both treatments had similar rates of persistent diarrhoea episodes (2%).", "population_specificity": "Children aged 3-35 months with a history of watery diarrhoea for 72 hours or less.", "effective_dosage": "Not specified", "study_duration": "Follow-up at 16 days of illness", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:35.658170+00:00"}
{"study_id": 29016, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the gastric emptying rates and electrolyte concentration changes of different oral rehydration solutions (ORS) in horses at rest and after exercise.", "results_summary": "The study found that 90% of the ORS was emptied from the stomach within 15 minutes of administration, regardless of solution type or exercise condition. Electrolyte concentrations did not differ between treatments but changed significantly over time, suggesting gastric emptying does not significantly impact rehydration.", "population_specificity": "Standardbred horses", "effective_dosage": "Single dose of 8 liters via nasogastric tube", "study_duration": "Measurements taken at 15-minute intervals for one hour", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:36.387589+00:00"}
{"study_id": 29013, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether modified tapioca starch (Textra) improves sodium, potassium, water, and glucose absorption in oral rehydration solutions for malnourished and well-fed rats.", "results_summary": "In protein-deficient rats, Textra significantly enhanced sodium, potassium, and water absorption at 5 g/l and 10 g/l, with glucose absorption improving only at 10 g/l. In well-fed rats, Textra improved sodium and water absorption at 5 g/l but not at 10 g/l, with no effect on potassium absorption or water influx:efflux ratio.", "population_specificity": "Protein-deficient and well-fed rats.", "effective_dosage": "0 g/l, 5 g/l, and 10 g/l of Textra in oral rehydration solution.", "study_duration": "Not specified (one-pass jejunal perfusion).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:37.210431+00:00"}
{"study_id": 29017, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to compare the effects of a conventional (WHO-type) and a nutritional oral rehydration solution (ORS) on plasma urea, creatinine, and glomerular filtration rate (GFR) in calves with diarrhea.", "results_summary": "The study found that changes in urea and creatinine did not accurately reflect pre-renal failure. The nutritional ORS improved GFR, while the WHO-type solution worsened it further.", "population_specificity": "Calves with diarrhea", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:38.846234+00:00"}
{"study_id": 29014, "supplement_id": 1400, "safety_score": "75", "efficacy_score": 60, "quality_score": 85, "study_goal": "The researchers aimed to determine if cereal-based oral rehydration solutions (CBORS) could be safely and effectively prepared and administered by low-income parents, and if CBORS were as effective as commercial glucose-based ORS in maintaining hydration and reducing illness severity.", "results_summary": "CBORS did not show a clinically significant advantage over glucose-based ORS. Mixing errors occurred in a small percentage of cases, but most children had normal serum sodium levels. Children refused CBORS more often than Pedialyte, and fluid intake was lower in CBORS groups, but there were no significant differences in vomiting, stooling, or duration of diarrhea.", "population_specificity": "Children aged 4 to 36 months discharged from emergency departments and health centers with acute diarrheal disease.", "effective_dosage": "Not specified", "study_duration": "Until illness resolved (daily follow-up by study nurse)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:38.955296+00:00"}
{"study_id": 29019, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of an oral electrolyte solution made with rice syrup solids versus a glucose-based solution in reducing fecal output and promoting fluid and electrolyte absorption in infants with diarrhea.", "results_summary": "The rice syrup solids solution reduced fecal output more effectively than the glucose-based solution in the early hours of treatment and improved absorption of fluid, sodium, and potassium. In some infants, this rapid rehydration may prevent hospitalization.", "population_specificity": "Infants with diarrhea", "effective_dosage": "Not specified", "study_duration": "Early hours of treatment (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:40.829124+00:00"}
{"study_id": 29018, "supplement_id": 1400, "safety_score": "90", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the acceptability of prepackaged rice-based and flavored glucose-based ORS solutions with standard glucose-based ORS and determine if presenting rice-based ORS as a diarrhea-stopping solution enhanced its acceptability.", "results_summary": "The study found no significant difference in ORS consumption among the three types (rice-based, flavored, and standard glucose-based). Presenting rice-based ORS as a diarrhea-stopping solution did not increase consumption. Reactions to all ORS types were favorable but similar across groups.", "population_specificity": "437 non-dehydrated children under five years old with acute diarrhea.", "effective_dosage": "Not specified (consumption measured in mL/kg/24 h).", "study_duration": "24- or 48-hour follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:41.116714+00:00"}
{"study_id": 29022, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 65, "study_goal": "The researchers aimed to examine the volume and duration of oral rehydration solution administration in children with diarrhea and assess the influence of maternal knowledge and contextual factors.", "results_summary": "The study found that oral rehydration solutions were given in smaller volumes and for shorter durations than recommended, with low daily administration rates. Most children received other fluids, but their effectiveness in preventing dehydration was unclear.", "population_specificity": "Children with diarrhea and their mothers across seven sites in Africa, Asia, and Latin America.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:43.885055+00:00"}
{"study_id": 29021, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to determine whether adding 90 mmol/L L-glutamine to standard WHO-ORS provided any additional therapeutic benefit for treating dehydration in infants with acute non-cholera diarrhea.", "results_summary": "The study found no significant difference in diarrheal stool output, duration of diarrhea, or ORS volume required for hydration between the glutamine-based ORS and standard WHO-ORS groups. The glutamine-based ORS did not offer any additional therapeutic advantage over standard WHO-ORS.", "population_specificity": "Male infants aged >1 month and <1 year with acute non-cholera diarrhea and dehydration.", "effective_dosage": "90 mmol/L L-glutamine added to standard WHO-ORS.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:45.491835+00:00"}
{"study_id": 29025, "supplement_id": 1400, "safety_score": "85", "efficacy_score": 80, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effectiveness of oral rehydration solutions (containing 60-90 mmol/l of sodium) combined with diuretics in managing mild neonatal hyperparathyroidism as an alternative to surgical intervention.", "results_summary": "The study found that oral rehydration solutions, when combined with diuretics, successfully maintained normal serum calcium levels in a neonate with primary hyperparathyroidism. The approach was deemed a viable initial treatment for mild cases, posing no specific risks.", "population_specificity": "Neonates with mild primary hyperparathyroidism.", "effective_dosage": "Oral rehydration solutions containing 60-90 mmol/l of sodium (frequency not specified).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:48.108595+00:00"}
{"study_id": 29030, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of different oral rehydration solutions (ORS) on intestinal water and electrolyte transport in humans.", "results_summary": "Solution VI (hypotonic ORS) demonstrated the highest water absorption, significantly outperforming other solutions, including the WHO standard (solution II). Sodium absorption was highest with solution II, but solution VI still showed clinically meaningful absorption.", "population_specificity": "Humans (specific demographics not detailed in the abstract).", "effective_dosage": "Various compositions (mmol/l) of ORS were tested (solutions II-VI).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:49.638880+00:00"}
{"study_id": 29029, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to compare the efficacy of first-generation (glucosalan and citroglucosalan) and second-generation (rice and salt-based) oral rehydration solutions (ORS) in treating patients with acute intestinal infections.", "results_summary": "The study found that second-generation ORS (rice and salt-based) was more effective than first-generation solutions, providing not only detoxification and rehydration but also serving as a food source. Clinical and biochemical parameters supported these findings.", "population_specificity": "150 patients with food toxicoinfections.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:49.644705+00:00"}
{"study_id": 29024, "supplement_id": 1400, "safety_score": "90", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy and safety of two oral rehydration solutions (Gastrolyte and Glucolyte) in children with acute gastroenteritis and mild to moderate dehydration.", "results_summary": "Gastrolyte resulted in significantly fewer vomiting episodes and lower stool volume compared to Glucolyte, though differences in dehydration correction, diarrhea duration, and hospital stay were not significant. No adverse drug reactions occurred, and oral rehydration therapy was deemed safe and effective.", "population_specificity": "Children aged 1-10 years with acute gastroenteritis and mild or moderate dehydration (n = 45).", "effective_dosage": "Gastrolyte (60 mmol/l sodium, 1.8% glucose, 240 mosm/l) and Glucolyte (26 mmol/l sodium, 2.7% glucose, 3.6% sucrose, 340 mOsm/l).", "study_duration": "Up to 24 hours (with specific analysis at 8 hours and 0-24 hours).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:49.843494+00:00"}
{"study_id": 29031, "supplement_id": 1400, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to compare the effectiveness and safety of two oral rehydration solutions (ORS-90 and ORS-60) in treating acute diarrhea in infants, focusing on osmolality differences.", "results_summary": "The study found that ORS-60 (lower osmolality) resulted in fewer cases requiring intravenous rehydration (2.5%) compared to ORS-90 (8.3%). Both solutions corrected hypernatremia and hyponatremia similarly, with no significant differences in sodium or potassium levels.", "population_specificity": "186 infants suffering from acute diarrhea.", "effective_dosage": "ORS-90 (sodium 60 mmol/L, glucose 90 mmol/L, osmolality 311 mOsm/kg) and ORS-60 (sodium 60 mmol/L, glucose 90 mmol/L, osmolality 240 mOsm/kg).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:54.546460+00:00"}
{"study_id": 29028, "supplement_id": 1400, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness and advantages of glucose polymer-based oral rehydration solutions (primarily rice-based) against traditional glucose-based solutions in treating acute diarrhea.", "results_summary": "The study found that glucose polymers from rice-based solutions were absorbed faster, reduced diarrhea duration and volume, and improved net absorption of glucose, sodium, and water compared to glucose-based solutions. These solutions also offered cost benefits and avoided osmotic overload.", "population_specificity": "Rats (small intestine absorption study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:55.249597+00:00"}
{"study_id": 29023, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of glucose-based and cereal-based oral rehydration solutions and a mixed meal on jejunal water and ionic transport in dogs.", "results_summary": "Both glucose-based and cereal-based rehydration solutions significantly increased jejunal absorption of water and electrolytes, with no difference between the two solutions, though both were less effective than a mixed meal. The study suggests these effects may be mediated by a neurohumoral mechanism independent of direct luminal nutrient contact.", "population_specificity": "Dogs with proximal jejunal Thiry-Vella fistulae.", "effective_dosage": "Not specified.", "study_duration": "Each study consisted of a 1-hour basal period followed by a 3-hour experimental period.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:56.945980+00:00"}
{"study_id": 29032, "supplement_id": 1400, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy and safety of two oral rehydration solutions (ORS-60 and ORS-26) in children and infants with acute diarrhea and mild to moderate dehydration.", "results_summary": "ORS-60 significantly reduced stool volume within the first eight hours compared to ORS-26, led to earlier cessation of diarrhea (64% vs. 31% by 24 hours), and improved clinical condition in more patients (84% vs. 60%). No adverse drug reactions occurred, and no significant differences were found in dehydration levels, total diarrhea duration, or hospital stay.", "population_specificity": "Children and infants with acute diarrhea and mild to moderate dehydration.", "effective_dosage": "ORS-60 (60 mmol/L sodium, 1.8% glucose); ORS-26 (26 mmol/L sodium, 2.7% glucose, 3.6% sucrose).", "study_duration": "Intervention effects were assessed up to 24 hours, with follow-up points for clinical condition and dehydration.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:57.365294+00:00"}
{"study_id": 29033, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the optimal composition of oral rehydration solutions (ORS) and compare new formulations to established ones using animal models.", "results_summary": "The study found that hypotonic ORS (osmolality \u2264240 mosm/kg) with sodium concentrations of 50-60 mmol/L and glucose concentrations of 90-111 mmol/L showed superior water absorption. Animal models also supported the use of glucose polymer and food-based ORS, though results must be interpreted cautiously due to physiologic limitations.", "population_specificity": "Healthy and diseased small intestine of rats (rotavirus-infected or cholera toxin-exposed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:57.598455+00:00"}
{"study_id": 29034, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of two oral rehydration solutions (ORS 1 and ORS 2) in treating dehydration and diarrhea in calves, focusing on plasma volume expansion and acidosis correction.", "results_summary": "ORS 2 demonstrated superior performance in water absorption, plasma volume expansion, acidosis correction, and peripheral perfusion compared to ORS 1, though mortality rates in clinical cases did not differ significantly.", "population_specificity": "Calves (isolated intestinal loops, experimentally dehydrated, experimentally induced diarrhea, and clinical cases of diarrhea).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:58.298676+00:00"}
{"study_id": 29036, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare gastric emptying patterns of rice powder electrolyte solution and glucose electrolyte solution in acute cholera patients and recovered individuals.", "results_summary": "The study found no differences in gastric emptying between the two solutions during acute cholera or recovery, with rapid emptying observed in both cases, supporting their clinical efficacy in fast purging cholera patients.", "population_specificity": "Adult patients with acute cholera, some re-tested 16 days post-recovery.", "effective_dosage": "Not specified", "study_duration": "Single administration during acute phase and repeat 16 days later.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:58.469262+00:00"}
{"study_id": 29037, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy of cereal-based oral rehydration solutions (maize, millet, sorghum, rice) against the standard WHO/Unicef glucose-based solution in treating acute diarrhoea with moderate to severe dehydration.", "results_summary": "The study found that all cereal-based oral rehydration solutions were as effective as the standard glucose-based solution in terms of intake, stool output, duration of diarrhoea, and weight gain at 24, 48, and 72 hours post-treatment.", "population_specificity": "257 boys aged 4-55 months with acute diarrhoea and moderate to severe dehydration.", "effective_dosage": "Not specified", "study_duration": "Until diarrhoea stopped", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:59.198619+00:00"}
{"study_id": 29039, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to compare the efficacy of three training methods for rural women in correctly reconstituting Oral Rehydration Solutions (ORS).", "results_summary": "Group II, which received verbal instructions plus a demonstration, achieved near-ideal ORS reconstitution, followed by Group III (using pre-marked bags) and Group I (verbal instructions only).", "population_specificity": "Rural women", "effective_dosage": "Entire contents of a sachet in half a litre of water", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:59:03.437827+00:00"}
{"study_id": 29038, "supplement_id": 1400, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the safety and efficacy of three different oral rehydration solutions (ORS) with varying sodium, glucose, and glycine compositions in treating acute gastroenteritis in young children.", "results_summary": "All three ORS formulations were safe and effective for rehydration and correcting biochemical abnormalities, with similar clinical outcomes across groups. However, carbohydrate intolerance was more prevalent in children who received the high-glucose ORS.", "population_specificity": "Children under 2 years old admitted to a London hospital with acute gastroenteritis.", "effective_dosage": "Three ORS formulations: (1) Na+ 35, glucose 200 mmol/L; (2) Na+ 60, glucose 111 mmol/L; (3) Na+ 50, glucose 50, glycine 50 mmol/L.", "study_duration": "Not explicitly stated, but outcomes were assessed at 24 hours.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:59:05.629612+00:00"}
{"study_id": 29041, "supplement_id": 1400, "safety_score": "70", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the usage rates and safety of home-made oral rehydration solutions (LGS) in preventing dehydration due to diarrhoea in a community programme in Bangladesh.", "results_summary": "The overall usage of LGS for all diarrhoea episodes was 5-10%, but for severe diarrhoea or cholera, it was 25-52%. Mothers' ability to prepare a safe solution declined after six months and was worse in the Second Phase of the programme.", "population_specificity": "Households in Bangladesh, particularly mothers trained by the BRAC programme.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:59:06.247645+00:00"}
{"study_id": 29044, "supplement_id": 1400, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the need for improved oral rehydration solutions (ORS) and assess experimental models for developing and testing new formulations.", "results_summary": "The abstract highlights that oral rehydration therapy is effective for mild to moderate dehydration but notes the lack of a definitive model for assessing ORS formulations. Various techniques, such as radioactive tracer methods and perfusion techniques, are used to study gastric emptying and intestinal absorption, though each has limitations.", "population_specificity": "Patients suffering from mild to moderate dehydration.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:59:06.814582+00:00"}
